{
  "cells": [
    {
      "cell_type": "code",
      "execution_count": 1,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 1000
        },
        "id": "speOzR0QuqBU",
        "outputId": "69cbac0c-4ed5-4f68-e6da-40522967911d"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "Collecting PyMuPDF\n",
            "  Downloading pymupdf-1.26.6-cp310-abi3-macosx_10_9_x86_64.whl.metadata (3.4 kB)\n",
            "Collecting pdfminer.six\n",
            "  Downloading pdfminer_six-20251107-py3-none-any.whl.metadata (4.2 kB)\n",
            "Collecting tiktoken\n",
            "  Downloading tiktoken-0.12.0-cp313-cp313-macosx_10_13_x86_64.whl.metadata (6.7 kB)\n",
            "Collecting langchain==1.0\n",
            "  Downloading langchain-1.0.0-py3-none-any.whl.metadata (4.6 kB)\n",
            "Collecting langchain-community\n",
            "  Downloading langchain_community-0.4.1-py3-none-any.whl.metadata (3.0 kB)\n",
            "Collecting langchain-google-genai\n",
            "  Downloading langchain_google_genai-3.1.0-py3-none-any.whl.metadata (2.7 kB)\n",
            "Collecting langchain-huggingface\n",
            "  Downloading langchain_huggingface-1.0.1-py3-none-any.whl.metadata (2.1 kB)\n",
            "Collecting langchain-pinecone\n",
            "  Downloading langchain_pinecone-0.2.13-py3-none-any.whl.metadata (8.6 kB)\n",
            "Collecting pinecone\n",
            "  Downloading pinecone-8.0.0-py3-none-any.whl.metadata (11 kB)\n",
            "Collecting pinecone-text\n",
            "  Downloading pinecone_text-0.11.0-py3-none-any.whl.metadata (10 kB)\n",
            "Collecting rank_bm25\n",
            "  Downloading rank_bm25-0.2.2-py3-none-any.whl.metadata (3.2 kB)\n",
            "Collecting tools\n",
            "  Downloading tools-1.0.13-py3-none-any.whl.metadata (1.3 kB)\n",
            "Collecting transformers\n",
            "  Downloading transformers-4.57.1-py3-none-any.whl.metadata (43 kB)\n",
            "Collecting pillow\n",
            "  Downloading pillow-12.0.0-cp313-cp313-macosx_10_13_x86_64.whl.metadata (8.8 kB)\n",
            "Collecting langchain-core<2.0.0,>=1.0.0 (from langchain==1.0)\n",
            "  Downloading langchain_core-1.1.0-py3-none-any.whl.metadata (3.6 kB)\n",
            "Collecting langgraph<1.1.0,>=1.0.0 (from langchain==1.0)\n",
            "  Downloading langgraph-1.0.3-py3-none-any.whl.metadata (7.8 kB)\n",
            "Collecting pydantic<3.0.0,>=2.7.4 (from langchain==1.0)\n",
            "  Downloading pydantic-2.12.4-py3-none-any.whl.metadata (89 kB)\n",
            "Collecting charset-normalizer>=2.0.0 (from pdfminer.six)\n",
            "  Downloading charset_normalizer-3.4.4-cp313-cp313-macosx_10_13_universal2.whl.metadata (37 kB)\n",
            "Collecting cryptography>=36.0.0 (from pdfminer.six)\n",
            "  Downloading cryptography-46.0.3-cp311-abi3-macosx_10_9_universal2.whl.metadata (5.7 kB)\n",
            "Collecting regex>=2022.1.18 (from tiktoken)\n",
            "  Downloading regex-2025.11.3-cp313-cp313-macosx_10_13_x86_64.whl.metadata (40 kB)\n",
            "Collecting requests>=2.26.0 (from tiktoken)\n",
            "  Downloading requests-2.32.5-py3-none-any.whl.metadata (4.9 kB)\n",
            "Collecting langchain-classic<2.0.0,>=1.0.0 (from langchain-community)\n",
            "  Downloading langchain_classic-1.0.0-py3-none-any.whl.metadata (3.9 kB)\n",
            "Collecting SQLAlchemy<3.0.0,>=1.4.0 (from langchain-community)\n",
            "  Downloading sqlalchemy-2.0.44-cp313-cp313-macosx_10_13_x86_64.whl.metadata (9.5 kB)\n",
            "Collecting PyYAML<7.0.0,>=5.3.0 (from langchain-community)\n",
            "  Downloading pyyaml-6.0.3-cp313-cp313-macosx_10_13_x86_64.whl.metadata (2.4 kB)\n",
            "Collecting aiohttp<4.0.0,>=3.8.3 (from langchain-community)\n",
            "  Downloading aiohttp-3.13.2-cp313-cp313-macosx_10_13_x86_64.whl.metadata (8.1 kB)\n",
            "Collecting tenacity!=8.4.0,<10.0.0,>=8.1.0 (from langchain-community)\n",
            "  Downloading tenacity-9.1.2-py3-none-any.whl.metadata (1.2 kB)\n",
            "Collecting dataclasses-json<0.7.0,>=0.6.7 (from langchain-community)\n",
            "  Downloading dataclasses_json-0.6.7-py3-none-any.whl.metadata (25 kB)\n",
            "Collecting pydantic-settings<3.0.0,>=2.10.1 (from langchain-community)\n",
            "  Downloading pydantic_settings-2.12.0-py3-none-any.whl.metadata (3.4 kB)\n",
            "Collecting langsmith<1.0.0,>=0.1.125 (from langchain-community)\n",
            "  Downloading langsmith-0.4.46-py3-none-any.whl.metadata (14 kB)\n",
            "Collecting httpx-sse<1.0.0,>=0.4.0 (from langchain-community)\n",
            "  Downloading httpx_sse-0.4.3-py3-none-any.whl.metadata (9.7 kB)\n",
            "Requirement already satisfied: numpy>=2.1.0 in /Users/soham/opt/anaconda3/envs/spark/lib/python3.13/site-packages (from langchain-community) (2.2.4)\n",
            "Collecting filetype<2.0.0,>=1.2.0 (from langchain-google-genai)\n",
            "  Downloading filetype-1.2.0-py2.py3-none-any.whl.metadata (6.5 kB)\n",
            "Collecting google-ai-generativelanguage<1.0.0,>=0.9.0 (from langchain-google-genai)\n",
            "  Downloading google_ai_generativelanguage-0.9.0-py3-none-any.whl.metadata (10 kB)\n",
            "Collecting huggingface-hub<1.0.0,>=0.33.4 (from langchain-huggingface)\n",
            "  Downloading huggingface_hub-0.36.0-py3-none-any.whl.metadata (14 kB)\n",
            "Collecting tokenizers<1.0.0,>=0.19.1 (from langchain-huggingface)\n",
            "  Downloading tokenizers-0.22.1-cp39-abi3-macosx_10_12_x86_64.whl.metadata (6.8 kB)\n",
            "Collecting pinecone\n",
            "  Downloading pinecone-7.3.0-py3-none-any.whl.metadata (9.5 kB)\n",
            "Collecting langchain-openai>=0.3.11 (from langchain-pinecone)\n",
            "  Downloading langchain_openai-1.0.3-py3-none-any.whl.metadata (2.6 kB)\n",
            "Collecting httpx>=0.28.0 (from langchain-pinecone)\n",
            "  Downloading httpx-0.28.1-py3-none-any.whl.metadata (7.1 kB)\n",
            "Collecting simsimd>=5.9.11 (from langchain-pinecone)\n",
            "  Downloading simsimd-6.5.3-cp313-cp313-macosx_10_13_x86_64.whl.metadata (70 kB)\n",
            "Collecting certifi>=2019.11.17 (from pinecone)\n",
            "  Downloading certifi-2025.11.12-py3-none-any.whl.metadata (2.5 kB)\n",
            "Collecting pinecone-plugin-assistant<2.0.0,>=1.6.0 (from pinecone)\n",
            "  Downloading pinecone_plugin_assistant-1.8.0-py3-none-any.whl.metadata (30 kB)\n",
            "Collecting pinecone-plugin-interface<0.0.8,>=0.0.7 (from pinecone)\n",
            "  Downloading pinecone_plugin_interface-0.0.7-py3-none-any.whl.metadata (1.2 kB)\n",
            "Requirement already satisfied: python-dateutil>=2.5.3 in /Users/soham/opt/anaconda3/envs/spark/lib/python3.13/site-packages (from pinecone) (2.9.0.post0)\n",
            "Collecting typing-extensions>=3.7.4 (from pinecone)\n",
            "  Downloading typing_extensions-4.15.0-py3-none-any.whl.metadata (3.3 kB)\n",
            "Collecting urllib3>=1.26.5 (from pinecone)\n",
            "  Downloading urllib3-2.5.0-py3-none-any.whl.metadata (6.5 kB)\n",
            "Collecting mmh3<5.0.0,>=4.1.0 (from pinecone-text)\n",
            "  Downloading mmh3-4.1.0.tar.gz (26 kB)\n",
            "  Installing build dependencies ... \u001b[?25ldone\n",
            "\u001b[?25h  Getting requirements to build wheel ... \u001b[?25ldone\n",
            "\u001b[?25h  Preparing metadata (pyproject.toml) ... \u001b[?25ldone\n",
            "\u001b[?25hCollecting nltk<4.0.0,>=3.9.1 (from pinecone-text)\n",
            "  Downloading nltk-3.9.2-py3-none-any.whl.metadata (3.2 kB)\n",
            "Requirement already satisfied: python-dotenv<2.0.0,>=1.0.1 in /Users/soham/opt/anaconda3/envs/spark/lib/python3.13/site-packages (from pinecone-text) (1.1.0)\n",
            "Collecting types-requests<3.0.0,>=2.25.0 (from pinecone-text)\n",
            "  Downloading types_requests-2.32.4.20250913-py3-none-any.whl.metadata (2.0 kB)\n",
            "Collecting filelock (from transformers)\n",
            "  Downloading filelock-3.20.0-py3-none-any.whl.metadata (2.1 kB)\n",
            "Requirement already satisfied: packaging>=20.0 in /Users/soham/opt/anaconda3/envs/spark/lib/python3.13/site-packages (from transformers) (24.2)\n",
            "Collecting safetensors>=0.4.3 (from transformers)\n",
            "  Downloading safetensors-0.7.0-cp38-abi3-macosx_10_12_x86_64.whl.metadata (4.1 kB)\n",
            "Collecting tqdm>=4.27 (from transformers)\n",
            "  Using cached tqdm-4.67.1-py3-none-any.whl.metadata (57 kB)\n",
            "Collecting aiohappyeyeballs>=2.5.0 (from aiohttp<4.0.0,>=3.8.3->langchain-community)\n",
            "  Using cached aiohappyeyeballs-2.6.1-py3-none-any.whl.metadata (5.9 kB)\n",
            "Collecting aiosignal>=1.4.0 (from aiohttp<4.0.0,>=3.8.3->langchain-community)\n",
            "  Downloading aiosignal-1.4.0-py3-none-any.whl.metadata (3.7 kB)\n",
            "Collecting attrs>=17.3.0 (from aiohttp<4.0.0,>=3.8.3->langchain-community)\n",
            "  Downloading attrs-25.4.0-py3-none-any.whl.metadata (10 kB)\n",
            "Collecting frozenlist>=1.1.1 (from aiohttp<4.0.0,>=3.8.3->langchain-community)\n",
            "  Downloading frozenlist-1.8.0-cp313-cp313-macosx_10_13_x86_64.whl.metadata (20 kB)\n",
            "Collecting multidict<7.0,>=4.5 (from aiohttp<4.0.0,>=3.8.3->langchain-community)\n",
            "  Downloading multidict-6.7.0-cp313-cp313-macosx_10_13_x86_64.whl.metadata (5.3 kB)\n",
            "Collecting propcache>=0.2.0 (from aiohttp<4.0.0,>=3.8.3->langchain-community)\n",
            "  Downloading propcache-0.4.1-cp313-cp313-macosx_10_13_x86_64.whl.metadata (13 kB)\n",
            "Collecting yarl<2.0,>=1.17.0 (from aiohttp<4.0.0,>=3.8.3->langchain-community)\n",
            "  Downloading yarl-1.22.0-cp313-cp313-macosx_10_13_x86_64.whl.metadata (75 kB)\n",
            "Collecting cffi>=2.0.0 (from cryptography>=36.0.0->pdfminer.six)\n",
            "  Downloading cffi-2.0.0-cp313-cp313-macosx_10_13_x86_64.whl.metadata (2.6 kB)\n",
            "Collecting marshmallow<4.0.0,>=3.18.0 (from dataclasses-json<0.7.0,>=0.6.7->langchain-community)\n",
            "  Downloading marshmallow-3.26.1-py3-none-any.whl.metadata (7.3 kB)\n",
            "Collecting typing-inspect<1,>=0.4.0 (from dataclasses-json<0.7.0,>=0.6.7->langchain-community)\n",
            "  Downloading typing_inspect-0.9.0-py3-none-any.whl.metadata (1.5 kB)\n",
            "Collecting google-api-core!=2.0.*,!=2.1.*,!=2.10.*,!=2.2.*,!=2.3.*,!=2.4.*,!=2.5.*,!=2.6.*,!=2.7.*,!=2.8.*,!=2.9.*,<3.0.0,>=1.34.1 (from google-api-core[grpc]!=2.0.*,!=2.1.*,!=2.10.*,!=2.2.*,!=2.3.*,!=2.4.*,!=2.5.*,!=2.6.*,!=2.7.*,!=2.8.*,!=2.9.*,<3.0.0,>=1.34.1->google-ai-generativelanguage<1.0.0,>=0.9.0->langchain-google-genai)\n",
            "  Downloading google_api_core-2.28.1-py3-none-any.whl.metadata (3.3 kB)\n",
            "Collecting google-auth!=2.24.0,!=2.25.0,<3.0.0,>=2.14.1 (from google-ai-generativelanguage<1.0.0,>=0.9.0->langchain-google-genai)\n",
            "  Downloading google_auth-2.43.0-py2.py3-none-any.whl.metadata (6.6 kB)\n",
            "Collecting grpcio<2.0.0,>=1.33.2 (from google-ai-generativelanguage<1.0.0,>=0.9.0->langchain-google-genai)\n",
            "  Downloading grpcio-1.76.0-cp313-cp313-macosx_11_0_universal2.whl.metadata (3.7 kB)\n",
            "Collecting proto-plus<2.0.0,>=1.22.3 (from google-ai-generativelanguage<1.0.0,>=0.9.0->langchain-google-genai)\n",
            "  Using cached proto_plus-1.26.1-py3-none-any.whl.metadata (2.2 kB)\n",
            "Collecting protobuf!=4.21.0,!=4.21.1,!=4.21.2,!=4.21.3,!=4.21.4,!=4.21.5,<7.0.0,>=3.20.2 (from google-ai-generativelanguage<1.0.0,>=0.9.0->langchain-google-genai)\n",
            "  Downloading protobuf-6.33.1-cp39-abi3-macosx_10_9_universal2.whl.metadata (593 bytes)\n",
            "Collecting anyio (from httpx>=0.28.0->langchain-pinecone)\n",
            "  Downloading anyio-4.11.0-py3-none-any.whl.metadata (4.1 kB)\n",
            "Collecting httpcore==1.* (from httpx>=0.28.0->langchain-pinecone)\n",
            "  Downloading httpcore-1.0.9-py3-none-any.whl.metadata (21 kB)\n",
            "Collecting idna (from httpx>=0.28.0->langchain-pinecone)\n",
            "  Downloading idna-3.11-py3-none-any.whl.metadata (8.4 kB)\n",
            "Collecting h11>=0.16 (from httpcore==1.*->httpx>=0.28.0->langchain-pinecone)\n",
            "  Downloading h11-0.16.0-py3-none-any.whl.metadata (8.3 kB)\n",
            "Collecting fsspec>=2023.5.0 (from huggingface-hub<1.0.0,>=0.33.4->langchain-huggingface)\n",
            "  Downloading fsspec-2025.10.0-py3-none-any.whl.metadata (10 kB)\n",
            "Collecting hf-xet<2.0.0,>=1.1.3 (from huggingface-hub<1.0.0,>=0.33.4->langchain-huggingface)\n",
            "  Downloading hf_xet-1.2.0-cp37-abi3-macosx_10_12_x86_64.whl.metadata (4.9 kB)\n",
            "Collecting langchain-text-splitters<2.0.0,>=1.0.0 (from langchain-classic<2.0.0,>=1.0.0->langchain-community)\n",
            "  Downloading langchain_text_splitters-1.0.0-py3-none-any.whl.metadata (2.6 kB)\n",
            "Collecting jsonpatch<2.0.0,>=1.33.0 (from langchain-core<2.0.0,>=1.0.0->langchain==1.0)\n",
            "  Downloading jsonpatch-1.33-py2.py3-none-any.whl.metadata (3.0 kB)\n",
            "Collecting openai<3.0.0,>=1.109.1 (from langchain-openai>=0.3.11->langchain-pinecone)\n",
            "  Downloading openai-2.8.1-py3-none-any.whl.metadata (29 kB)\n",
            "Collecting langgraph-checkpoint<4.0.0,>=2.1.0 (from langgraph<1.1.0,>=1.0.0->langchain==1.0)\n",
            "  Downloading langgraph_checkpoint-3.0.1-py3-none-any.whl.metadata (4.7 kB)\n",
            "Collecting langgraph-prebuilt<1.1.0,>=1.0.2 (from langgraph<1.1.0,>=1.0.0->langchain==1.0)\n",
            "  Downloading langgraph_prebuilt-1.0.5-py3-none-any.whl.metadata (5.2 kB)\n",
            "Collecting langgraph-sdk<0.3.0,>=0.2.2 (from langgraph<1.1.0,>=1.0.0->langchain==1.0)\n",
            "  Downloading langgraph_sdk-0.2.9-py3-none-any.whl.metadata (1.5 kB)\n",
            "Collecting xxhash>=3.5.0 (from langgraph<1.1.0,>=1.0.0->langchain==1.0)\n",
            "  Downloading xxhash-3.6.0-cp313-cp313-macosx_10_13_x86_64.whl.metadata (13 kB)\n",
            "Collecting orjson>=3.9.14 (from langsmith<1.0.0,>=0.1.125->langchain-community)\n",
            "  Downloading orjson-3.11.4-cp313-cp313-macosx_10_15_x86_64.macosx_11_0_arm64.macosx_10_15_universal2.whl.metadata (41 kB)\n",
            "Collecting requests-toolbelt>=1.0.0 (from langsmith<1.0.0,>=0.1.125->langchain-community)\n",
            "  Downloading requests_toolbelt-1.0.0-py2.py3-none-any.whl.metadata (14 kB)\n",
            "Collecting zstandard>=0.23.0 (from langsmith<1.0.0,>=0.1.125->langchain-community)\n",
            "  Downloading zstandard-0.25.0-cp313-cp313-macosx_10_13_x86_64.whl.metadata (3.3 kB)\n",
            "Collecting click (from nltk<4.0.0,>=3.9.1->pinecone-text)\n",
            "  Downloading click-8.3.1-py3-none-any.whl.metadata (2.6 kB)\n",
            "Collecting joblib (from nltk<4.0.0,>=3.9.1->pinecone-text)\n",
            "  Downloading joblib-1.5.2-py3-none-any.whl.metadata (5.6 kB)\n",
            "Collecting aiohttp-retry<3.0.0,>=2.9.1 (from pinecone[asyncio]<8.0.0,>=6.0.0->langchain-pinecone)\n",
            "  Downloading aiohttp_retry-2.9.1-py3-none-any.whl.metadata (8.8 kB)\n",
            "Collecting annotated-types>=0.6.0 (from pydantic<3.0.0,>=2.7.4->langchain==1.0)\n",
            "  Using cached annotated_types-0.7.0-py3-none-any.whl.metadata (15 kB)\n",
            "Collecting pydantic-core==2.41.5 (from pydantic<3.0.0,>=2.7.4->langchain==1.0)\n",
            "  Downloading pydantic_core-2.41.5-cp313-cp313-macosx_10_12_x86_64.whl.metadata (7.3 kB)\n",
            "Collecting typing-inspection>=0.4.2 (from pydantic<3.0.0,>=2.7.4->langchain==1.0)\n",
            "  Downloading typing_inspection-0.4.2-py3-none-any.whl.metadata (2.6 kB)\n",
            "Requirement already satisfied: six>=1.5 in /Users/soham/opt/anaconda3/envs/spark/lib/python3.13/site-packages (from python-dateutil>=2.5.3->pinecone) (1.17.0)\n",
            "Collecting greenlet>=1 (from SQLAlchemy<3.0.0,>=1.4.0->langchain-community)\n",
            "  Downloading greenlet-3.2.4-cp313-cp313-macosx_11_0_universal2.whl.metadata (4.1 kB)\n",
            "Collecting pycparser (from cffi>=2.0.0->cryptography>=36.0.0->pdfminer.six)\n",
            "  Downloading pycparser-2.23-py3-none-any.whl.metadata (993 bytes)\n",
            "Collecting googleapis-common-protos<2.0.0,>=1.56.2 (from google-api-core!=2.0.*,!=2.1.*,!=2.10.*,!=2.2.*,!=2.3.*,!=2.4.*,!=2.5.*,!=2.6.*,!=2.7.*,!=2.8.*,!=2.9.*,<3.0.0,>=1.34.1->google-api-core[grpc]!=2.0.*,!=2.1.*,!=2.10.*,!=2.2.*,!=2.3.*,!=2.4.*,!=2.5.*,!=2.6.*,!=2.7.*,!=2.8.*,!=2.9.*,<3.0.0,>=1.34.1->google-ai-generativelanguage<1.0.0,>=0.9.0->langchain-google-genai)\n",
            "  Downloading googleapis_common_protos-1.72.0-py3-none-any.whl.metadata (9.4 kB)\n",
            "Collecting grpcio-status<2.0.0,>=1.33.2 (from google-api-core[grpc]!=2.0.*,!=2.1.*,!=2.10.*,!=2.2.*,!=2.3.*,!=2.4.*,!=2.5.*,!=2.6.*,!=2.7.*,!=2.8.*,!=2.9.*,<3.0.0,>=1.34.1->google-ai-generativelanguage<1.0.0,>=0.9.0->langchain-google-genai)\n",
            "  Using cached grpcio_status-1.76.0-py3-none-any.whl.metadata (1.1 kB)\n",
            "Collecting cachetools<7.0,>=2.0.0 (from google-auth!=2.24.0,!=2.25.0,<3.0.0,>=2.14.1->google-ai-generativelanguage<1.0.0,>=0.9.0->langchain-google-genai)\n",
            "  Downloading cachetools-6.2.2-py3-none-any.whl.metadata (5.6 kB)\n",
            "Collecting pyasn1-modules>=0.2.1 (from google-auth!=2.24.0,!=2.25.0,<3.0.0,>=2.14.1->google-ai-generativelanguage<1.0.0,>=0.9.0->langchain-google-genai)\n",
            "  Using cached pyasn1_modules-0.4.2-py3-none-any.whl.metadata (3.5 kB)\n",
            "Collecting rsa<5,>=3.1.4 (from google-auth!=2.24.0,!=2.25.0,<3.0.0,>=2.14.1->google-ai-generativelanguage<1.0.0,>=0.9.0->langchain-google-genai)\n",
            "  Using cached rsa-4.9.1-py3-none-any.whl.metadata (5.6 kB)\n",
            "Collecting jsonpointer>=1.9 (from jsonpatch<2.0.0,>=1.33.0->langchain-core<2.0.0,>=1.0.0->langchain==1.0)\n",
            "  Downloading jsonpointer-3.0.0-py2.py3-none-any.whl.metadata (2.3 kB)\n",
            "Collecting ormsgpack>=1.12.0 (from langgraph-checkpoint<4.0.0,>=2.1.0->langgraph<1.1.0,>=1.0.0->langchain==1.0)\n",
            "  Downloading ormsgpack-1.12.0-cp313-cp313-macosx_10_12_x86_64.macosx_11_0_arm64.macosx_10_12_universal2.whl.metadata (1.2 kB)\n",
            "Collecting distro<2,>=1.7.0 (from openai<3.0.0,>=1.109.1->langchain-openai>=0.3.11->langchain-pinecone)\n",
            "  Downloading distro-1.9.0-py3-none-any.whl.metadata (6.8 kB)\n",
            "Collecting jiter<1,>=0.10.0 (from openai<3.0.0,>=1.109.1->langchain-openai>=0.3.11->langchain-pinecone)\n",
            "  Downloading jiter-0.12.0-cp313-cp313-macosx_10_12_x86_64.whl.metadata (5.2 kB)\n",
            "Collecting sniffio (from openai<3.0.0,>=1.109.1->langchain-openai>=0.3.11->langchain-pinecone)\n",
            "  Downloading sniffio-1.3.1-py3-none-any.whl.metadata (3.9 kB)\n",
            "Collecting mypy-extensions>=0.3.0 (from typing-inspect<1,>=0.4.0->dataclasses-json<0.7.0,>=0.6.7->langchain-community)\n",
            "  Downloading mypy_extensions-1.1.0-py3-none-any.whl.metadata (1.1 kB)\n",
            "Collecting pyasn1<0.7.0,>=0.6.1 (from pyasn1-modules>=0.2.1->google-auth!=2.24.0,!=2.25.0,<3.0.0,>=2.14.1->google-ai-generativelanguage<1.0.0,>=0.9.0->langchain-google-genai)\n",
            "  Using cached pyasn1-0.6.1-py3-none-any.whl.metadata (8.4 kB)\n",
            "Downloading langchain-1.0.0-py3-none-any.whl (106 kB)\n",
            "Downloading pymupdf-1.26.6-cp310-abi3-macosx_10_9_x86_64.whl (23.2 MB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m23.2/23.2 MB\u001b[0m \u001b[31m28.4 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0ma \u001b[36m0:00:01\u001b[0m\n",
            "\u001b[?25hDownloading pdfminer_six-20251107-py3-none-any.whl (5.6 MB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m5.6/5.6 MB\u001b[0m \u001b[31m32.6 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hDownloading tiktoken-0.12.0-cp313-cp313-macosx_10_13_x86_64.whl (1.1 MB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m1.1/1.1 MB\u001b[0m \u001b[31m10.0 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hDownloading langchain_community-0.4.1-py3-none-any.whl (2.5 MB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m2.5/2.5 MB\u001b[0m \u001b[31m26.6 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hDownloading langchain_google_genai-3.1.0-py3-none-any.whl (55 kB)\n",
            "Downloading langchain_huggingface-1.0.1-py3-none-any.whl (27 kB)\n",
            "Downloading langchain_pinecone-0.2.13-py3-none-any.whl (26 kB)\n",
            "Downloading pinecone-7.3.0-py3-none-any.whl (587 kB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m587.6/587.6 kB\u001b[0m \u001b[31m9.2 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hDownloading pinecone_text-0.11.0-py3-none-any.whl (22 kB)\n",
            "Downloading rank_bm25-0.2.2-py3-none-any.whl (8.6 kB)\n",
            "Downloading tools-1.0.13-py3-none-any.whl (41 kB)\n",
            "Downloading transformers-4.57.1-py3-none-any.whl (12.0 MB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m12.0/12.0 MB\u001b[0m \u001b[31m38.9 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m \u001b[36m0:00:01\u001b[0m\n",
            "\u001b[?25hDownloading pillow-12.0.0-cp313-cp313-macosx_10_13_x86_64.whl (5.2 MB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m5.2/5.2 MB\u001b[0m \u001b[31m32.9 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hDownloading aiohttp-3.13.2-cp313-cp313-macosx_10_13_x86_64.whl (490 kB)\n",
            "Downloading certifi-2025.11.12-py3-none-any.whl (159 kB)\n",
            "Downloading charset_normalizer-3.4.4-cp313-cp313-macosx_10_13_universal2.whl (208 kB)\n",
            "Downloading cryptography-46.0.3-cp311-abi3-macosx_10_9_universal2.whl (7.2 MB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m7.2/7.2 MB\u001b[0m \u001b[31m35.1 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hDownloading dataclasses_json-0.6.7-py3-none-any.whl (28 kB)\n",
            "Downloading filetype-1.2.0-py2.py3-none-any.whl (19 kB)\n",
            "Downloading google_ai_generativelanguage-0.9.0-py3-none-any.whl (1.4 MB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m1.4/1.4 MB\u001b[0m \u001b[31m13.2 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hDownloading httpx-0.28.1-py3-none-any.whl (73 kB)\n",
            "Downloading httpcore-1.0.9-py3-none-any.whl (78 kB)\n",
            "Downloading httpx_sse-0.4.3-py3-none-any.whl (9.0 kB)\n",
            "Downloading huggingface_hub-0.36.0-py3-none-any.whl (566 kB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m566.1/566.1 kB\u001b[0m \u001b[31m7.2 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hDownloading langchain_classic-1.0.0-py3-none-any.whl (1.0 MB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m1.0/1.0 MB\u001b[0m \u001b[31m13.2 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hDownloading langchain_core-1.1.0-py3-none-any.whl (473 kB)\n",
            "Downloading langchain_openai-1.0.3-py3-none-any.whl (82 kB)\n",
            "Downloading langgraph-1.0.3-py3-none-any.whl (156 kB)\n",
            "Downloading langsmith-0.4.46-py3-none-any.whl (411 kB)\n",
            "Downloading nltk-3.9.2-py3-none-any.whl (1.5 MB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m1.5/1.5 MB\u001b[0m \u001b[31m21.0 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hDownloading pinecone_plugin_assistant-1.8.0-py3-none-any.whl (259 kB)\n",
            "Downloading pinecone_plugin_interface-0.0.7-py3-none-any.whl (6.2 kB)\n",
            "Downloading pydantic-2.12.4-py3-none-any.whl (463 kB)\n",
            "Downloading pydantic_core-2.41.5-cp313-cp313-macosx_10_12_x86_64.whl (2.1 MB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m2.1/2.1 MB\u001b[0m \u001b[31m48.3 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hDownloading pydantic_settings-2.12.0-py3-none-any.whl (51 kB)\n",
            "Downloading pyyaml-6.0.3-cp313-cp313-macosx_10_13_x86_64.whl (181 kB)\n",
            "Downloading regex-2025.11.3-cp313-cp313-macosx_10_13_x86_64.whl (291 kB)\n",
            "Downloading requests-2.32.5-py3-none-any.whl (64 kB)\n",
            "Downloading safetensors-0.7.0-cp38-abi3-macosx_10_12_x86_64.whl (467 kB)\n",
            "Downloading simsimd-6.5.3-cp313-cp313-macosx_10_13_x86_64.whl (177 kB)\n",
            "Downloading sqlalchemy-2.0.44-cp313-cp313-macosx_10_13_x86_64.whl (2.1 MB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m2.1/2.1 MB\u001b[0m \u001b[31m23.1 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hDownloading tenacity-9.1.2-py3-none-any.whl (28 kB)\n",
            "Downloading tokenizers-0.22.1-cp39-abi3-macosx_10_12_x86_64.whl (3.1 MB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m3.1/3.1 MB\u001b[0m \u001b[31m29.9 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hUsing cached tqdm-4.67.1-py3-none-any.whl (78 kB)\n",
            "Downloading types_requests-2.32.4.20250913-py3-none-any.whl (20 kB)\n",
            "Downloading typing_extensions-4.15.0-py3-none-any.whl (44 kB)\n",
            "Downloading urllib3-2.5.0-py3-none-any.whl (129 kB)\n",
            "Downloading filelock-3.20.0-py3-none-any.whl (16 kB)\n",
            "Using cached aiohappyeyeballs-2.6.1-py3-none-any.whl (15 kB)\n",
            "Downloading aiohttp_retry-2.9.1-py3-none-any.whl (10.0 kB)\n",
            "Downloading aiosignal-1.4.0-py3-none-any.whl (7.5 kB)\n",
            "Using cached annotated_types-0.7.0-py3-none-any.whl (13 kB)\n",
            "Downloading attrs-25.4.0-py3-none-any.whl (67 kB)\n",
            "Downloading cffi-2.0.0-cp313-cp313-macosx_10_13_x86_64.whl (185 kB)\n",
            "Downloading frozenlist-1.8.0-cp313-cp313-macosx_10_13_x86_64.whl (49 kB)\n",
            "Downloading fsspec-2025.10.0-py3-none-any.whl (200 kB)\n",
            "Downloading google_api_core-2.28.1-py3-none-any.whl (173 kB)\n",
            "Downloading google_auth-2.43.0-py2.py3-none-any.whl (223 kB)\n",
            "Downloading greenlet-3.2.4-cp313-cp313-macosx_11_0_universal2.whl (272 kB)\n",
            "Downloading grpcio-1.76.0-cp313-cp313-macosx_11_0_universal2.whl (11.8 MB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m11.8/11.8 MB\u001b[0m \u001b[31m32.8 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m \u001b[36m0:00:01\u001b[0m\n",
            "\u001b[?25hDownloading hf_xet-1.2.0-cp37-abi3-macosx_10_12_x86_64.whl (2.9 MB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m2.9/2.9 MB\u001b[0m \u001b[31m20.4 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hDownloading idna-3.11-py3-none-any.whl (71 kB)\n",
            "Downloading jsonpatch-1.33-py2.py3-none-any.whl (12 kB)\n",
            "Downloading langchain_text_splitters-1.0.0-py3-none-any.whl (33 kB)\n",
            "Downloading langgraph_checkpoint-3.0.1-py3-none-any.whl (46 kB)\n",
            "Downloading langgraph_prebuilt-1.0.5-py3-none-any.whl (35 kB)\n",
            "Downloading langgraph_sdk-0.2.9-py3-none-any.whl (56 kB)\n",
            "Downloading marshmallow-3.26.1-py3-none-any.whl (50 kB)\n",
            "Downloading multidict-6.7.0-cp313-cp313-macosx_10_13_x86_64.whl (45 kB)\n",
            "Downloading openai-2.8.1-py3-none-any.whl (1.0 MB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m1.0/1.0 MB\u001b[0m \u001b[31m15.3 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hDownloading anyio-4.11.0-py3-none-any.whl (109 kB)\n",
            "Downloading orjson-3.11.4-cp313-cp313-macosx_10_15_x86_64.macosx_11_0_arm64.macosx_10_15_universal2.whl (243 kB)\n",
            "Downloading propcache-0.4.1-cp313-cp313-macosx_10_13_x86_64.whl (44 kB)\n",
            "Using cached proto_plus-1.26.1-py3-none-any.whl (50 kB)\n",
            "Downloading protobuf-6.33.1-cp39-abi3-macosx_10_9_universal2.whl (427 kB)\n",
            "Downloading requests_toolbelt-1.0.0-py2.py3-none-any.whl (54 kB)\n",
            "Downloading typing_inspect-0.9.0-py3-none-any.whl (8.8 kB)\n",
            "Downloading typing_inspection-0.4.2-py3-none-any.whl (14 kB)\n",
            "Downloading xxhash-3.6.0-cp313-cp313-macosx_10_13_x86_64.whl (32 kB)\n",
            "Downloading yarl-1.22.0-cp313-cp313-macosx_10_13_x86_64.whl (93 kB)\n",
            "Downloading zstandard-0.25.0-cp313-cp313-macosx_10_13_x86_64.whl (795 kB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m795.7/795.7 kB\u001b[0m \u001b[31m11.3 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hDownloading click-8.3.1-py3-none-any.whl (108 kB)\n",
            "Downloading joblib-1.5.2-py3-none-any.whl (308 kB)\n",
            "Downloading cachetools-6.2.2-py3-none-any.whl (11 kB)\n",
            "Downloading distro-1.9.0-py3-none-any.whl (20 kB)\n",
            "Downloading googleapis_common_protos-1.72.0-py3-none-any.whl (297 kB)\n",
            "Downloading grpcio_status-1.76.0-py3-none-any.whl (14 kB)\n",
            "Downloading h11-0.16.0-py3-none-any.whl (37 kB)\n",
            "Downloading jiter-0.12.0-cp313-cp313-macosx_10_12_x86_64.whl (313 kB)\n",
            "Downloading jsonpointer-3.0.0-py2.py3-none-any.whl (7.6 kB)\n",
            "Downloading mypy_extensions-1.1.0-py3-none-any.whl (5.0 kB)\n",
            "Downloading ormsgpack-1.12.0-cp313-cp313-macosx_10_12_x86_64.macosx_11_0_arm64.macosx_10_12_universal2.whl (369 kB)\n",
            "Using cached pyasn1_modules-0.4.2-py3-none-any.whl (181 kB)\n",
            "Using cached rsa-4.9.1-py3-none-any.whl (34 kB)\n",
            "Downloading sniffio-1.3.1-py3-none-any.whl (10 kB)\n",
            "Downloading pycparser-2.23-py3-none-any.whl (118 kB)\n",
            "Using cached pyasn1-0.6.1-py3-none-any.whl (83 kB)\n",
            "Building wheels for collected packages: mmh3\n",
            "  Building wheel for mmh3 (pyproject.toml) ... \u001b[?25ldone\n",
            "\u001b[?25h  Created wheel for mmh3: filename=mmh3-4.1.0-cp313-cp313-macosx_10_15_x86_64.whl size=28785 sha256=fc5517682dc9944edfe6d5eb4c70d735da27ece217720e476e034dfb4c2cdf07\n",
            "  Stored in directory: /Users/soham/Library/Caches/pip/wheels/57/68/ca/1b7f541c188850a92dc3011ea464115ab2171bff64606c54f5\n",
            "Successfully built mmh3\n",
            "Installing collected packages: simsimd, mmh3, filetype, zstandard, xxhash, urllib3, typing-extensions, tqdm, tools, tenacity, sniffio, safetensors, regex, rank_bm25, PyYAML, PyMuPDF, pycparser, pyasn1, protobuf, propcache, pinecone-plugin-interface, pillow, ormsgpack, orjson, mypy-extensions, multidict, marshmallow, jsonpointer, joblib, jiter, idna, httpx-sse, hf-xet, h11, greenlet, fsspec, frozenlist, filelock, distro, click, charset-normalizer, certifi, cachetools, attrs, annotated-types, aiohappyeyeballs, yarl, typing-inspection, typing-inspect, types-requests, SQLAlchemy, rsa, requests, pydantic-core, pyasn1-modules, proto-plus, nltk, jsonpatch, httpcore, grpcio, googleapis-common-protos, cffi, anyio, aiosignal, tiktoken, requests-toolbelt, pydantic, pinecone-text, pinecone-plugin-assistant, huggingface-hub, httpx, grpcio-status, google-auth, dataclasses-json, cryptography, aiohttp, tokenizers, pydantic-settings, pinecone, pdfminer.six, openai, langsmith, langgraph-sdk, google-api-core, aiohttp-retry, transformers, langchain-core, langgraph-checkpoint, langchain-text-splitters, langchain-openai, langchain-huggingface, google-ai-generativelanguage, langgraph-prebuilt, langchain-pinecone, langchain-google-genai, langchain-classic, langgraph, langchain-community, langchain\n",
            "Successfully installed PyMuPDF-1.26.6 PyYAML-6.0.3 SQLAlchemy-2.0.44 aiohappyeyeballs-2.6.1 aiohttp-3.13.2 aiohttp-retry-2.9.1 aiosignal-1.4.0 annotated-types-0.7.0 anyio-4.11.0 attrs-25.4.0 cachetools-6.2.2 certifi-2025.11.12 cffi-2.0.0 charset-normalizer-3.4.4 click-8.3.1 cryptography-46.0.3 dataclasses-json-0.6.7 distro-1.9.0 filelock-3.20.0 filetype-1.2.0 frozenlist-1.8.0 fsspec-2025.10.0 google-ai-generativelanguage-0.9.0 google-api-core-2.28.1 google-auth-2.43.0 googleapis-common-protos-1.72.0 greenlet-3.2.4 grpcio-1.76.0 grpcio-status-1.76.0 h11-0.16.0 hf-xet-1.2.0 httpcore-1.0.9 httpx-0.28.1 httpx-sse-0.4.3 huggingface-hub-0.36.0 idna-3.11 jiter-0.12.0 joblib-1.5.2 jsonpatch-1.33 jsonpointer-3.0.0 langchain-1.0.0 langchain-classic-1.0.0 langchain-community-0.4.1 langchain-core-1.1.0 langchain-google-genai-3.1.0 langchain-huggingface-1.0.1 langchain-openai-1.0.3 langchain-pinecone-0.2.13 langchain-text-splitters-1.0.0 langgraph-1.0.3 langgraph-checkpoint-3.0.1 langgraph-prebuilt-1.0.5 langgraph-sdk-0.2.9 langsmith-0.4.46 marshmallow-3.26.1 mmh3-4.1.0 multidict-6.7.0 mypy-extensions-1.1.0 nltk-3.9.2 openai-2.8.1 orjson-3.11.4 ormsgpack-1.12.0 pdfminer.six-20251107 pillow-12.0.0 pinecone-7.3.0 pinecone-plugin-assistant-1.8.0 pinecone-plugin-interface-0.0.7 pinecone-text-0.11.0 propcache-0.4.1 proto-plus-1.26.1 protobuf-6.33.1 pyasn1-0.6.1 pyasn1-modules-0.4.2 pycparser-2.23 pydantic-2.12.4 pydantic-core-2.41.5 pydantic-settings-2.12.0 rank_bm25-0.2.2 regex-2025.11.3 requests-2.32.5 requests-toolbelt-1.0.0 rsa-4.9.1 safetensors-0.7.0 simsimd-6.5.3 sniffio-1.3.1 tenacity-9.1.2 tiktoken-0.12.0 tokenizers-0.22.1 tools-1.0.13 tqdm-4.67.1 transformers-4.57.1 types-requests-2.32.4.20250913 typing-extensions-4.15.0 typing-inspect-0.9.0 typing-inspection-0.4.2 urllib3-2.5.0 xxhash-3.6.0 yarl-1.22.0 zstandard-0.25.0\n"
          ]
        }
      ],
      "source": [
        "!pip install PyMuPDF pdfminer.six tiktoken langchain==1.0 langchain-community langchain-google-genai langchain-huggingface langchain-pinecone pinecone pinecone-text rank_bm25 tools transformers pillow"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "3DaQHSJbur1q"
      },
      "outputs": [],
      "source": [
        "import os\n",
        "from dotenv import load_dotenv\n",
        "load_dotenv()\n",
        "PINECONE_API_KEY = os.environ.get(\"PINECONE_API_KEY\", \"\")\n",
        "GOOGLE_API_KEY = os.environ.get(\"GEMINI_API_KEY\", \"\")\n",
        "TEXT_INDEX = \"who-text-index\"\n",
        "IMAGE_INDEX = \"who-image-index\"\n",
        "NAMESPACE = \"who-pdf\"\n",
        "\n",
        "DENSE_MODEL = \"sentence-transformers/all-MiniLM-L6-v2\"\n",
        "IMAGE_MODEL = \"openai/clip-vit-base-patch32\""
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "L9IfxR-4u4Pv"
      },
      "source": [
        "## Data Processing & Storage\n",
        "\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 2,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "G29UyqetvCIp",
        "outputId": "9647d01f-61c0-4c2a-c367-65340d9fbd50"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "Method 1: Using text formatting detection\n",
            "==================================================\n",
            "Extracted: Figure 1.1 -> page_1_Figure_11.png\n",
            "Extracted: Figure 1.2 -> page_2_Figure_12.png\n",
            "Extracted: Figure 1.3 -> page_3_Figure_13.png\n",
            "Extracted: Figure 1.4 -> page_4_Figure_14.png\n",
            "Extracted: Figure 1.5 -> page_5_Figure_15.png\n",
            "Extracted: Figure 1.6 -> page_6_Figure_16.png\n",
            "Extracted: Figure 1.7 -> page_7_Figure_17.png\n",
            "Extracted: Figure 1.8 -> page_8_Figure_18.png\n",
            "Extracted: Figure 1.9 -> page_9_Figure_19.png\n",
            "Extracted: Figure 1.10 -> page_10_Figure_110.png\n",
            "Extracted: Figure 1.11 -> page_11_Figure_111.png\n",
            "Extracted: Figure 1.12 -> page_13_Figure_112.png\n",
            "Extracted: Figure 1.13 -> page_15_Figure_113.png\n",
            "Extracted: Figure 2.1 -> page_19_Figure_21.png\n",
            "Extracted: Figure 2.2 -> page_20_Figure_22.png\n",
            "Extracted: Figure 2.3 -> page_22_Figure_23_shows_the_coverage_of_immunization_with_malaria_and_other_vaccines_in_the_MVIP_areas_in_the_three.png\n",
            "Extracted: Figure 2.3 -> page_22_Figure_23.png\n",
            "Extracted: Figure 2.4 -> page_24_Figure_24.png\n",
            "Extracted: Figure 2.5 -> page_26_Figure_25.png\n",
            "Extracted: Figure 2.6 -> page_30_Figure_26.png\n",
            "Extracted: Figure 2.7 -> page_32_Figure_27.png\n",
            "Extracted: Figure 2.8 -> page_34_Figure_28.png\n",
            "Extracted: Figure 2.9 -> page_34_Figure_29.png\n",
            "Extracted: Figure 2.10 -> page_36_Figure_210.png\n",
            "Extracted: Figure 2.11 -> page_38_Figure_211.png\n",
            "Extracted: Figure 2.12 -> page_39_Figure_212.png\n",
            "Extracted: Figure 2.13 -> page_41_Figure_213.png\n",
            "Extracted: Figure 2.14 -> page_42_Figure_214.png\n",
            "Extracted: Figure 2.15 -> page_44_Figure_215.png\n",
            "Extracted: Figure 2.16 -> page_45_Figure_216.png\n",
            "Extracted: Figure 2.17 -> page_46_Figure_217.png\n",
            "JSON metadata saved: figures_method1/figures_metadata.json\n",
            "\n",
            "Total figures extracted: 31\n",
            "Metadata saved in: figures_method1/\n"
          ]
        }
      ],
      "source": [
        "import fitz  # PyMuPDF\n",
        "import re\n",
        "import json\n",
        "import csv\n",
        "from pathlib import Path\n",
        "from datetime import datetime\n",
        "\n",
        "def extract_figures_from_pdf(pdf_path, output_folder=\"extracted_figures\"):\n",
        "    \"\"\"\n",
        "    Extract figures from PDF by detecting figure captions and cropping regions.\n",
        "\n",
        "    Args:\n",
        "        pdf_path: Path to the PDF file\n",
        "        output_folder: Folder to save extracted figures\n",
        "    \"\"\"\n",
        "    # Create output folder\n",
        "    Path(output_folder).mkdir(exist_ok=True)\n",
        "\n",
        "    # Open PDF\n",
        "    doc = fitz.open(pdf_path)\n",
        "    figures_extracted = []\n",
        "    metadata = []\n",
        "\n",
        "    for page_num in range(len(doc)):\n",
        "        page = doc[page_num]\n",
        "\n",
        "        # Get all text blocks with formatting info\n",
        "        blocks = page.get_text(\"dict\")[\"blocks\"]\n",
        "\n",
        "        figure_regions = []\n",
        "\n",
        "        for block in blocks:\n",
        "            if \"lines\" not in block:\n",
        "                continue\n",
        "\n",
        "            for line in block[\"lines\"]:\n",
        "                for span in line[\"spans\"]:\n",
        "                    text = span[\"text\"].strip()\n",
        "                    text = text.split('\\n')\n",
        "                    if len(text)> 1 and text[0]==\"\":\n",
        "                        text = text[1]\n",
        "                    else:\n",
        "                        text = text[0]\n",
        "\n",
        "                    # Check if this looks like a figure caption\n",
        "                    # Pattern: \"Figure X.X\" or \"Figure X\"\n",
        "                    if re.match(r'^Figure\\s+\\d+\\.?\\d*', text, re.IGNORECASE):\n",
        "                        # Get the bounding box of this text\n",
        "                        bbox = span[\"bbox\"]\n",
        "\n",
        "                        # Check for bold and underline flags\n",
        "                        flags = span[\"flags\"]\n",
        "                        is_bold = flags & 2**4  # Bold flag\n",
        "\n",
        "                        # Store figure info\n",
        "                        figure_regions.append({\n",
        "                            \"caption\": text,\n",
        "                            \"y_position\": bbox[1],  # Top y-coordinate\n",
        "                            \"bbox\": bbox,\n",
        "                            \"page\": page_num\n",
        "                        })\n",
        "\n",
        "        # Process detected figures\n",
        "        for i, fig_info in enumerate(figure_regions):\n",
        "            # Determine the crop region\n",
        "            # Start from caption position\n",
        "            y_start = fig_info[\"y_position\"]\n",
        "\n",
        "            # End at next figure or page bottom\n",
        "            if i + 1 < len(figure_regions):\n",
        "                y_end = figure_regions[i + 1][\"y_position\"]\n",
        "            else:\n",
        "                y_end = page.rect.height\n",
        "\n",
        "            # Add some margin above caption (to include it)\n",
        "            margin_top = 20\n",
        "            margin_bottom = 20\n",
        "            margin_sides = 40\n",
        "\n",
        "            # Create crop rectangle\n",
        "            crop_rect = fitz.Rect(\n",
        "                margin_sides,  # left\n",
        "                max(0, y_start - margin_top),  # top\n",
        "                page.rect.width - margin_sides,  # right\n",
        "                min(page.rect.height, y_end + margin_bottom)  # bottom\n",
        "            )\n",
        "\n",
        "            # Extract the figure region\n",
        "            mat = fitz.Matrix(2, 2)  # 2x scale for better quality\n",
        "            pix = page.get_pixmap(matrix=mat, clip=crop_rect)\n",
        "\n",
        "            # Extract figure number from caption\n",
        "            figure_number_match = re.search(r'Figure\\s+(\\d+\\.?\\d*)', fig_info[\"caption\"], re.IGNORECASE)\n",
        "            figure_number = figure_number_match.group(1) if figure_number_match else \"unknown\"\n",
        "\n",
        "            # Get full caption text (may extend beyond first line)\n",
        "            caption_rect = fitz.Rect(fig_info[\"bbox\"][0], fig_info[\"bbox\"][1],\n",
        "                                    page.rect.width - margin_sides, fig_info[\"bbox\"][3] + 50)\n",
        "            full_caption = page.get_textbox(caption_rect).strip()\n",
        "\n",
        "            # Generate filename\n",
        "            caption_clean = re.sub(r'[^\\w\\s-]', '', fig_info[\"caption\"])\n",
        "            caption_clean = re.sub(r'\\s+', '_', caption_clean)\n",
        "            filename = f\"page_{page_num + 1}_{caption_clean}.png\"\n",
        "            filepath = f\"{output_folder}/{filename}\"\n",
        "\n",
        "            # Save image\n",
        "            pix.save(filepath)\n",
        "            figures_extracted.append(filepath)\n",
        "            # full_caption = full_caption.split(\"\\n\")\n",
        "            # full_caption = full_caption[0] if full_caption[0] != \"\" else full_caption[1]\n",
        "            # Create metadata entry\n",
        "            cleaned = re.sub(r'^Figure\\s+\\d+\\.\\d+\\s*\\n?', '', full_caption)\n",
        "            full_caption = cleaned.split('\\n')[0]\n",
        "            metadata_entry = {\n",
        "                \"figure_number\": figure_number,\n",
        "                \"caption\": full_caption,\n",
        "                \"filename\": filename,\n",
        "                \"filepath\": filepath,\n",
        "                \"page_number\": page_num + 1,\n",
        "                \"extraction_date\": datetime.now().isoformat()\n",
        "            }\n",
        "            metadata.append(metadata_entry)\n",
        "\n",
        "            print(f\"Extracted: Figure {figure_number} -> {filename}\")\n",
        "\n",
        "    doc.close()\n",
        "\n",
        "    # Save metadata\n",
        "    save_metadata(metadata, output_folder)\n",
        "\n",
        "    print(f\"\\nTotal figures extracted: {len(figures_extracted)}\")\n",
        "    print(f\"Metadata saved in: {output_folder}/\")\n",
        "    return figures_extracted, metadata\n",
        "\n",
        "\n",
        "def extract_figures_alternative(pdf_path, output_folder=\"extracted_figures_alt\"):\n",
        "    \"\"\"\n",
        "    Alternative method: Use text search to find figure captions.\n",
        "    More robust for different PDF encodings.\n",
        "    \"\"\"\n",
        "    Path(output_folder).mkdir(exist_ok=True)\n",
        "\n",
        "    doc = fitz.open(pdf_path)\n",
        "    all_figures = []\n",
        "    metadata = []\n",
        "\n",
        "    for page_num in range(len(doc)):\n",
        "        page = doc[page_num]\n",
        "\n",
        "        # Search for \"Figure\" text\n",
        "        figure_instances = page.search_for(\"Figure\", quads=False)\n",
        "\n",
        "        for rect in figure_instances:\n",
        "            # Get text near this position to get full caption\n",
        "            expanded_rect = fitz.Rect(rect.x0, rect.y0, page.rect.width, rect.y1 + 100)\n",
        "            caption_text = page.get_textbox(expanded_rect).strip().split('\\n')[0]\n",
        "\n",
        "            # Verify it's actually a figure caption\n",
        "            if re.match(r'^Figure\\s+\\d+', caption_text, re.IGNORECASE):\n",
        "                # Find next figure or end of page\n",
        "                y_start = rect.y0\n",
        "\n",
        "                # Look for next \"Figure\" occurrence\n",
        "                next_figures = [r for r in figure_instances if r.y0 > rect.y0 + 50]\n",
        "                if next_figures:\n",
        "                    y_end = next_figures[0].y0\n",
        "                else:\n",
        "                    y_end = page.rect.height\n",
        "\n",
        "                # Crop region\n",
        "                crop_rect = fitz.Rect(\n",
        "                    30,\n",
        "                    max(0, y_start - 15),\n",
        "                    page.rect.width - 30,\n",
        "                    min(page.rect.height, y_end + 10)\n",
        "                )\n",
        "\n",
        "                # Extract\n",
        "                mat = fitz.Matrix(2, 2)\n",
        "                pix = page.get_pixmap(matrix=mat, clip=crop_rect)\n",
        "\n",
        "                # Extract figure number\n",
        "                figure_number_match = re.search(r'Figure\\s+(\\d+\\.?\\d*)', caption_text, re.IGNORECASE)\n",
        "                figure_number = figure_number_match.group(1) if figure_number_match else \"unknown\"\n",
        "                # Filename\n",
        "                caption_clean = re.sub(r'[^\\w\\s-]', '', caption_text)\n",
        "                caption_clean = re.sub(r'\\s+', '_', caption_clean)[:50]\n",
        "                filename = f\"page_{page_num + 1}_{caption_clean}.png\"\n",
        "                filepath = f\"{output_folder}/{filename}\"\n",
        "\n",
        "                pix.save(filepath)\n",
        "                all_figures.append(filepath)\n",
        "                cleaned = re.sub(r'^Figure\\s+\\d+\\.\\d+\\s*\\n?', '', text)\n",
        "                caption_text = cleaned.split('\\n')[0]\n",
        "\n",
        "                # Create metadata entry\n",
        "                metadata_entry = {\n",
        "                    \"figure_number\": figure_number,\n",
        "                    \"caption\": caption_text,\n",
        "                    \"filename\": filename,\n",
        "                    \"filepath\": filepath,\n",
        "                    \"page_number\": page_num + 1,\n",
        "                    \"extraction_date\": datetime.now().isoformat()\n",
        "                }\n",
        "                metadata.append(metadata_entry)\n",
        "\n",
        "                print(f\"Extracted: Figure {figure_number} -> {filename}\")\n",
        "\n",
        "    doc.close()\n",
        "\n",
        "    # Save metadata\n",
        "    save_metadata(metadata, output_folder)\n",
        "\n",
        "    print(f\"\\nTotal figures extracted: {len(all_figures)}\")\n",
        "    print(f\"Metadata saved in: {output_folder}/\")\n",
        "    return all_figures, metadata\n",
        "\n",
        "\n",
        "def save_metadata(metadata, output_folder):\n",
        "    \"\"\"\n",
        "    Save metadata in multiple formats: JSON, CSV, and TXT.\n",
        "\n",
        "    Args:\n",
        "        metadata: List of metadata dictionaries\n",
        "        output_folder: Folder to save metadata files\n",
        "    \"\"\"\n",
        "    if not metadata:\n",
        "        print(\"No metadata to save.\")\n",
        "        return\n",
        "\n",
        "    # Save as JSON\n",
        "    json_path = f\"{output_folder}/figures_metadata.json\"\n",
        "    with open(json_path, 'w', encoding='utf-8') as f:\n",
        "        json.dump(metadata, f, indent=2, ensure_ascii=False)\n",
        "    print(f\"JSON metadata saved: {json_path}\")\n",
        "\n",
        "    # # Save as CSV\n",
        "    # csv_path = f\"{output_folder}/figures_metadata.csv\"\n",
        "    # with open(csv_path, 'w', newline='', encoding='utf-8') as f:\n",
        "    #     writer = csv.DictWriter(f, fieldnames=metadata[0].keys())\n",
        "    #     writer.writeheader()\n",
        "    #     writer.writerows(metadata)\n",
        "    # print(f\"CSV metadata saved: {csv_path}\")\n",
        "\n",
        "    # # Save as human-readable text\n",
        "    # txt_path = f\"{output_folder}/figures_metadata.txt\"\n",
        "    # with open(txt_path, 'w', encoding='utf-8') as f:\n",
        "    #     f.write(\"=\" * 80 + \"\\n\")\n",
        "    #     f.write(\"EXTRACTED FIGURES METADATA\\n\")\n",
        "    #     f.write(\"=\" * 80 + \"\\n\\n\")\n",
        "\n",
        "    #     for entry in metadata:\n",
        "    #         f.write(f\"Figure Number: {entry['figure_number']}\\n\")\n",
        "    #         f.write(f\"Caption: {entry['caption']}\\n\")\n",
        "    #         f.write(f\"Filename: {entry['filename']}\\n\")\n",
        "    #         f.write(f\"Page Number: {entry['page_number']}\\n\")\n",
        "    #         f.write(f\"Extraction Date: {entry['extraction_date']}\\n\")\n",
        "    #         f.write(\"-\" * 80 + \"\\n\\n\")\n",
        "    # print(f\"TXT metadata saved: {txt_path}\")\n",
        "\n",
        "\n",
        "def load_metadata(metadata_path):\n",
        "    \"\"\"\n",
        "    Load metadata from JSON file.\n",
        "\n",
        "    Args:\n",
        "        metadata_path: Path to JSON metadata file\n",
        "\n",
        "    Returns:\n",
        "        List of metadata dictionaries\n",
        "    \"\"\"\n",
        "    with open(metadata_path, 'r', encoding='utf-8') as f:\n",
        "        return json.load(f)\n",
        "\n",
        "\n",
        "def search_figures(metadata, search_term):\n",
        "    \"\"\"\n",
        "    Search figures by caption or figure number.\n",
        "\n",
        "    Args:\n",
        "        metadata: List of metadata dictionaries\n",
        "        search_term: Term to search for\n",
        "\n",
        "    Returns:\n",
        "        List of matching metadata entries\n",
        "    \"\"\"\n",
        "    results = []\n",
        "    search_lower = search_term.lower()\n",
        "\n",
        "    for entry in metadata:\n",
        "        if (search_lower in entry['caption'].lower() or\n",
        "            search_lower in entry['figure_number'].lower()):\n",
        "            results.append(entry)\n",
        "\n",
        "    return results\n",
        "\n",
        "\n",
        "# Usage example\n",
        "if __name__ == \"__main__\":\n",
        "    pdf_path = \"WHO_document.pdf\"  # Change this to your PDF path\n",
        "\n",
        "    print(\"Method 1: Using text formatting detection\")\n",
        "    print(\"=\" * 50)\n",
        "    try:\n",
        "        figures1, metadata1 = extract_figures_from_pdf(pdf_path, \"figures_method1\")\n",
        "\n",
        "    except Exception as e:\n",
        "        print(f\"Method 1 failed: {e}\")\n",
        "\n",
        "    # print(\"\\n\\nMethod 2: Using text search\")\n",
        "    # print(\"=\" * 50)\n",
        "    # try:\n",
        "    #     figures2, metadata2 = extract_figures_alternative(pdf_path, \"figures_method2\")\n",
        "\n",
        "    #     # Example: Load metadata later\n",
        "    #     print(\"\\n--- Reload Metadata Example ---\")\n",
        "    #     loaded_metadata = load_metadata(\"figures_method2/figures_metadata.json\")\n",
        "    #     print(f\"Loaded {len(loaded_metadata)} figure metadata entries\")\n",
        "\n",
        "    # except Exception as e:\n",
        "    #     print(f\"Method 2 failed: {e}\")"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "sOc1e87A-5wy"
      },
      "outputs": [],
      "source": [
        "# pip install pdfminer.six tiktoken\n",
        "from pdfminer.high_level import extract_pages\n",
        "from pdfminer.layout import LTTextContainer\n",
        "import re, tiktoken\n",
        "\n",
        "def extract_paragraph_docs(pdf_path, max_tokens=1200, overlap_tokens=120):\n",
        "    \"\"\"\n",
        "    Extract paragraphs from a PDF and return a list of dicts like\n",
        "    LangChain's create_documents output:\n",
        "        {\"page_content\": <text>, \"metadata\": {\"page\": <n>, \"para\": <m>}}\n",
        "    \"\"\"\n",
        "    enc = tiktoken.get_encoding(\"cl100k_base\")\n",
        "\n",
        "    def normalize_ws(s: str) -> str:\n",
        "        s = re.sub(r\"[ \\t]+\", \" \", s)\n",
        "        s = re.sub(r\" *\\n+\", \"\\n\", s)\n",
        "        return s.strip()\n",
        "\n",
        "    def merge_lines_to_paragraphs(lines):\n",
        "        paras, buf = [], []\n",
        "        for ln in lines:\n",
        "            t = ln.rstrip()\n",
        "            if not t:\n",
        "                if buf:\n",
        "                    paras.append(\" \".join(buf).strip())\n",
        "                    buf = []\n",
        "                continue\n",
        "            if t.endswith(\"-\"):\n",
        "                buf.append(t[:-1])  # de-hyphenate\n",
        "            else:\n",
        "                buf.append(t)\n",
        "        if buf:\n",
        "            paras.append(\" \".join(buf).strip())\n",
        "        return [p for p in paras if p]\n",
        "\n",
        "    docs = []\n",
        "    for page_no, layout in enumerate(extract_pages(pdf_path), 1):\n",
        "        lines = []\n",
        "        for element in layout:\n",
        "            if isinstance(element, LTTextContainer):\n",
        "                lines.extend(element.get_text().splitlines())\n",
        "        lines.append(\"\")  # ensure paragraph break at page end\n",
        "\n",
        "        paras = merge_lines_to_paragraphs([normalize_ws(x) for x in lines])\n",
        "\n",
        "        # token-aware sub-chunking\n",
        "        for para_idx, para in enumerate(paras, 1):\n",
        "            ids = enc.encode(para)\n",
        "            if len(ids) <= max_tokens:\n",
        "                docs.append({\n",
        "                    \"page_content\": para,\n",
        "                    \"metadata\": {\"page\": page_no, \"para\": para_idx}\n",
        "                })\n",
        "            else:\n",
        "                start = 0\n",
        "                sub_idx = 0\n",
        "                while start < len(ids):\n",
        "                    end = min(start + max_tokens, len(ids))\n",
        "                    sub_text = enc.decode(ids[start:end])\n",
        "                    docs.append({\n",
        "                        \"page_content\": sub_text,\n",
        "                        \"metadata\": {\"page\": page_no,\n",
        "                                     \"para\": para_idx,\n",
        "                                     \"sub\": sub_idx}\n",
        "                    })\n",
        "                    sub_idx += 1\n",
        "                    if end == len(ids): break\n",
        "                    start = max(end - overlap_tokens, end)\n",
        "\n",
        "    return docs\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "2EPNLB8F_Z53"
      },
      "outputs": [],
      "source": [
        "docs = extract_paragraph_docs(\"WHO_document.pdf\")"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "fzrAGt2yvw1w"
      },
      "outputs": [],
      "source": [
        "from langchain_text_splitters import RecursiveCharacterTextSplitter\n",
        "\n",
        "def build_text_vectors(docs):\n",
        "    vectors = []\n",
        "    for i, doc in enumerate(docs):\n",
        "        # dense = dense_text_embed(doc['page_content'])\n",
        "        metadata = doc['metadata'].copy()\n",
        "        # metadata[\"context\"] = doc['page_content'] # Add the text content under 'context' key\n",
        "\n",
        "        vectors.append({\n",
        "            \"id\": f\"text-{i}\",\n",
        "            \"chunk_text\": doc['page_content'],\n",
        "        })\n",
        "    return vectors\n",
        "\n",
        "# def build_image_vectors(images):\n",
        "#     vectors = []\n",
        "#     for i, img in enumerate(images):\n",
        "#         dense = dense_image_embed(img[\"bytes\"])\n",
        "#         vectors.append({\n",
        "#             \"id\": f\"{img['figure_number']}\",\n",
        "#             \"values\": dense,\n",
        "#             \"metadata\": {\"page\": img[\"page\"],\n",
        "#                          \"ext\": img[\"ext\"],\n",
        "#                          \"caption\": img[\"context\"]}\n",
        "#         })\n",
        "\n",
        "def build_image_caption_vectors(images):\n",
        "    vectors = []\n",
        "    for i, img in enumerate(images):\n",
        "      # dense = dense_text_embed(img[\"context\"])\n",
        "      vectors.append({\"_id\": f\"{img['figure_number']}\",\n",
        "                      \"chunk_text\": img['context'],\n",
        "                      \"filename\": img['filename'],\n",
        "                      \"caption\": img[\"context\"]})\n",
        "    return vectors\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "ofxNlS5MwR-b",
        "outputId": "037e91bf-7d41-4a53-bb2b-45cfc3074303"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "Loaded 31 images from extracted_charts folder.\n"
          ]
        }
      ],
      "source": [
        "import os\n",
        "from PIL import Image\n",
        "import io\n",
        "import json\n",
        "\n",
        "image_files = []\n",
        "image_dir = \"./figures_method1\"\n",
        "image_metadata = {}\n",
        "with open(os.path.join(image_dir, \"figures_metadata.json\"), \"r\") as fp:\n",
        "  json_data = json.load(fp)\n",
        "for entry in json_data:\n",
        "  image_metadata[entry['filename']] = entry\n",
        "\n",
        "for filename in os.listdir(image_dir):\n",
        "    if filename.endswith(\".png\"):\n",
        "        filepath = os.path.join(image_dir, filename)\n",
        "        with open(filepath, \"rb\") as f:\n",
        "            image_bytes = f.read()\n",
        "\n",
        "        # Extract page number from filename (e.g., page_1_figure_1.png -> page 1)\n",
        "        try:\n",
        "            page_num_str = filename.split('_')[1]\n",
        "            page_num = int(page_num_str) - 1 # Adjust to 0-indexed page\n",
        "        except (IndexError, ValueError):\n",
        "            page_num = -1 # Default if page number cannot be extracted\n",
        "\n",
        "        # table_path = os.path.join(\"extracted_tables\", os.path.basename(filename).replace(\".png\", \".txt\"))\n",
        "        # table_text = \"\"\n",
        "        # try:\n",
        "        #     with open(table_path, \"r\", encoding=\"utf-8\") as f:\n",
        "        #         table_text = f.readlines()\n",
        "        # except FileNotFoundError:\n",
        "        #     print(f\"No corresponding table found for {filename}\")\n",
        "        try:\n",
        "          im_info = image_metadata[filename]\n",
        "          page_num = im_info[\"page_number\"]\n",
        "          caption = im_info[\"caption\"]\n",
        "          figure_number = im_info[\"figure_number\"]\n",
        "        except:\n",
        "          continue\n",
        "        image_files.append({\n",
        "            \"page\": page_num,\n",
        "            \"bytes\": image_bytes,\n",
        "            \"ext\": \"png\",\n",
        "            \"context\": f\"Figure {figure_number}: {caption}\",\n",
        "            \"figure_number\": figure_number,\n",
        "            \"filename\": filename\n",
        "        })\n",
        "\n",
        "images = image_files\n",
        "print(f\"Loaded {len(images)} images from extracted_charts folder.\")"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "cKBolbQjEeVS",
        "outputId": "4c3edff6-61ec-4fb6-c50e-f0a624909e9e"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "Figure 1.2: Trends in life expectancy and HALE at birth, by sex and by WHO region, 2000–2021\n"
          ]
        }
      ],
      "source": [
        "print(images[-1][\"context\"])"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "iXc-w5bfwRKM"
      },
      "outputs": [],
      "source": [
        "\n",
        "\n",
        "# docs = split_text(pages)\n",
        "\n",
        "text_vectors = build_text_vectors(docs)\n",
        "# image_vectors = build_image_vectors(images)\n",
        "image_caption_vectors = build_image_caption_vectors(images)\n",
        "\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "x6pCWFTS4Lr1",
        "outputId": "9c15af1d-bb32-4e18-81f3-2acc98b24502"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "image_caption_vectors: 31\n"
          ]
        }
      ],
      "source": [
        "print(f\"image_caption_vectors: {len(image_caption_vectors)}\")\n",
        "# print(image_caption_vectors[0])"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "g7W5328l9vaW"
      },
      "source": [
        "##Store Embeddings in Pinecone"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "XRhJEqlntKaf"
      },
      "outputs": [],
      "source": [
        "from pinecone import Pinecone\n",
        "pc = Pinecone(api_key=PINECONE_API_KEY)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "Pz9HJ2zQtSFm"
      },
      "outputs": [],
      "source": [
        "# Run one time only\n",
        "if TEXT_INDEX in pc.list_indexes().names():\n",
        "    pc.delete_index(TEXT_INDEX)\n",
        "if IMAGE_INDEX in pc.list_indexes().names():\n",
        "    pc.delete_index(IMAGE_INDEX)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "vIEfzHsxtU5Q",
        "outputId": "9a960314-3d69-477f-a7fc-313f5a9217a7"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "Pinecone index who-text-index already exists.\n",
            "Pinecone index objects initialized for text_idx and image_idx.\n"
          ]
        }
      ],
      "source": [
        "# Check and create TEXT_INDEX\n",
        "if TEXT_INDEX not in pc.list_indexes().names():\n",
        "    print(f\"Creating Pinecone index: {TEXT_INDEX}...\")\n",
        "    # Create a dense index with integrated embedding\n",
        "    index_name = TEXT_INDEX\n",
        "    if not pc.has_index(index_name):\n",
        "        pc.create_index_for_model(\n",
        "            name=index_name,\n",
        "            cloud=\"aws\",\n",
        "            region=\"us-east-1\",\n",
        "            embed={\n",
        "                \"model\":\"llama-text-embed-v2\",\n",
        "                \"field_map\":{\"text\": \"chunk_text\"}\n",
        "            }\n",
        "        )\n",
        "    print(f\"Index {TEXT_INDEX} created.\")\n",
        "else:\n",
        "    print(f\"Pinecone index {TEXT_INDEX} already exists.\")\n",
        "\n",
        "SPARSE_TEXT_INDEX = TEXT_INDEX+\"-sparse\"\n",
        "if SPARSE_TEXT_INDEX not in pc.list_indexes().names():\n",
        "  print(f\"Creating Pinecone index: {SPARSE_TEXT_INDEX}...\")\n",
        "  # Create a dense index with integrated embedding\n",
        "  index_name = SPARSE_TEXT_INDEX\n",
        "  if not pc.has_index(index_name):\n",
        "    pc.create_index_for_model(\n",
        "        name=index_name,\n",
        "        cloud=\"aws\",\n",
        "        region=\"us-east-1\",\n",
        "        embed={\n",
        "            \"model\":\"pinecone-sparse-english-v0\",\n",
        "            \"field_map\":{\"text\": \"chunk_text\"}\n",
        "        }\n",
        "    )\n",
        "    print(f\"Index {TEXT_INDEX} created.\")\n",
        "  else:\n",
        "    print(f\"Pinecone index {TEXT_INDEX} already exists.\")\n",
        "\n",
        "# Check and create IMAGE_INDEX\n",
        "if IMAGE_INDEX not in pc.list_indexes().names():\n",
        "    print(f\"Creating Pinecone index: {IMAGE_INDEX}...\")\n",
        "    # Create a dense index with integrated embedding\n",
        "    index_name = IMAGE_INDEX\n",
        "    if not pc.has_index(index_name):\n",
        "        pc.create_index_for_model(\n",
        "            name=index_name,\n",
        "            cloud=\"aws\",\n",
        "            region=\"us-east-1\",\n",
        "            embed={\n",
        "                \"model\":\"llama-text-embed-v2\",\n",
        "                \"field_map\":{\"text\": \"chunk_text\"}\n",
        "            }\n",
        "        )\n",
        "\n",
        "# Initialize Pinecone Index objects\n",
        "text_idx = pc.Index(TEXT_INDEX)\n",
        "sp_text_ix = pc.Index(SPARSE_TEXT_INDEX)\n",
        "image_idx = pc.Index(IMAGE_INDEX)\n",
        "\n",
        "print(\"Pinecone index objects initialized for text_idx and image_idx.\")\n",
        "\n",
        "def upsert_text(vectors):\n",
        "    text_idx.upsert_records(\"WHO-doc\", vectors)\n",
        "    sp_text_ix.upsert_records(\"WHO-doc\", vectors)\n",
        "\n",
        "def upsert_images(vectors):\n",
        "    image_idx.upsert_records(\"WHO-doc\", vectors)\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "IgPa7TA8taUT"
      },
      "outputs": [],
      "source": [
        "upsert_text(text_vectors)\n",
        "# upsert_images(image_vectors)\n",
        "upsert_images(image_caption_vectors)"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "VZqVYIpr9zT7"
      },
      "source": [
        "##Retrieval System with Context Awareness"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "ZfczfaIFtblH"
      },
      "outputs": [],
      "source": [
        "import os\n",
        "from google.colab import userdata\n",
        "from langchain_google_genai import ChatGoogleGenerativeAI\n",
        "from google import genai\n",
        "LLM_MODEL_NAME = \"gemini-2.5-flash\"\n",
        "\n",
        "if \"GOOGLE_API_KEY\" not in os.environ:\n",
        "    GOOGLE_API_KEY = userdata.get(\"GEMINI_API_KEY\")\n",
        "    os.environ[\"GOOGLE_API_KEY\"] = GOOGLE_API_KEY\n",
        "\n",
        "client = genai.Client()\n",
        "\n",
        "\n",
        "\n",
        "REFORM_PROMPT = \"\"\"\n",
        "You are a concise search-query reformulator. Given conversation history and a user query,\n",
        "produce a single-line standalone search query that preserves intent and context.\n",
        "\n",
        "History:\n",
        "{history}\n",
        "\n",
        "User query:\n",
        "{query}\n",
        "\n",
        "Standalone query:\n",
        "\"\"\"\n",
        "\n",
        "def reformulate(query: str, history: list[str]) -> str:\n",
        "    history_text = \"\\n\".join(history[-6:])  # last N turns\n",
        "    prompt = REFORM_PROMPT.format(history=history_text, query=query)\n",
        "    response = client.models.generate_content(\n",
        "    model=LLM_MODEL_NAME,\n",
        "    contents=[prompt]\n",
        "    )\n",
        "    return response.text.strip()"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "iU6HL4chucpf"
      },
      "outputs": [],
      "source": [
        "from langchain_pinecone import PineconeRerank\n",
        "\n",
        "from langchain_community.retrievers import (\n",
        "    PineconeHybridSearchRetriever,\n",
        ")\n",
        "\n",
        "def retrieve_context(query: str, history: list[str] = None,\n",
        "                     top_k_text=10, top_k_rerank=5, top_k_images=3, img_threshold=0.5):\n",
        "\n",
        "    history = history or []\n",
        "    reform_q = reformulate(query, history)\n",
        "    # Search the dense index\n",
        "\n",
        "    dense_results = text_idx.search(\n",
        "        namespace=\"WHO-doc\",\n",
        "        query={\n",
        "            \"top_k\": 5,\n",
        "            \"inputs\": {\n",
        "                'text': reform_q\n",
        "            }\n",
        "        }\n",
        "    )\n",
        "    sparse_results = sp_text_ix.search(\n",
        "        namespace=\"WHO-doc\",\n",
        "        query={\n",
        "            \"top_k\": 5,\n",
        "            \"inputs\": {\n",
        "                'text': reform_q\n",
        "            }\n",
        "        }\n",
        "    )\n",
        "    # print(dense_results)\n",
        "    # print(sparse_results)\n",
        "    dense_documents = dense_results['result']['hits']\n",
        "    sp_documents = sparse_results['result']['hits']\n",
        "\n",
        "    docs = []\n",
        "\n",
        "    for doc in dense_documents:\n",
        "      docs.append({'_id': doc['_id'], 'chunk_text': doc['fields']['chunk_text']})\n",
        "    for doc in sp_documents:\n",
        "      docs.append({'_id': doc['_id'], 'chunk_text': doc['fields']['chunk_text']})\n",
        "\n",
        "    # print(docs)\n",
        "    ranked_results = pc.inference.rerank(\n",
        "      model=\"bge-reranker-v2-m3\",\n",
        "      query=reform_q,\n",
        "      documents= docs,\n",
        "      top_n=3,\n",
        "      rank_fields=[\"chunk_text\"],\n",
        "      return_documents=True,\n",
        "      parameters={\n",
        "          \"truncate\": \"END\"\n",
        "      }\n",
        "    )\n",
        "    # print(ranked_results)\n",
        "    top_docs = ranked_results.data\n",
        "    # top_docs = ranked_results['documents']\n",
        "    # print(f\"REFORMULATED_QUERY: {reform_q}\")\n",
        "    # result_text = text_retriever.invoke(reform_q)\n",
        "    # top3_docs = reranker_text.compress_documents(result_text, reform_q)\n",
        "    # # print(\"Top-3 Result:\")\n",
        "    # # for doc in top3_docs:\n",
        "    # #   print(f\"Score: {doc.metadata['relevance_score']:.4f} | Content: {doc.page_content}\")\n",
        "    image_results = image_idx.search(\n",
        "        namespace=\"WHO-doc\",\n",
        "        query={\n",
        "            \"top_k\": 3,\n",
        "            \"inputs\": {\n",
        "                'text': reform_q\n",
        "            }\n",
        "        }\n",
        "    )\n",
        "\n",
        "    image_documents = image_results['result']['hits']\n",
        "    # print(image_documents)\n",
        "    # filtered_images = []\n",
        "    # for img in result_images['matches']:\n",
        "    #   if img['score'] >= img_threshold:\n",
        "    #     filtered_images.append(img)\n",
        "    # # result_images['matches'] = filtered_images\n",
        "    return top_docs, image_documents"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "JfCLS-ktySFb"
      },
      "outputs": [],
      "source": [
        "question = 'What were the top causes of death globally in 2021?'\n",
        "docs, images = retrieve_context(question, history=None)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "YSBon5mK24fI",
        "outputId": "dbe6f1cb-7646-4e6e-af92-23c6b88f7eab"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "[{\n",
            "    index=0,\n",
            "    score=0.9981969,\n",
            "    document={\n",
            "        _id='text-8',\n",
            "        chunk_text='This distribution of the leading 10 causes of death by broad cause group at global level remained unchanged from 2019 in 2020 and 2021; however, COVID-19 emerged as the third and second leading causes, respectively, claiming 4.1 million and 8.8 million lives globally. In all but two WHO regions (the African and Western Pacific regions), COVID-19 ranked among the top five causes of deaths in 2020 and 2021, responsible for the largest number of deaths in both years in the Region of the Americas, in 2021 in the South-East Asia Region and the second largest number of deaths in both years in the European and the Eastern Mediterranean regions. In the African Region, the disease only moved up from 12th to sixth in 2021. While in the Western Pacific Region it remained out of the top 10, it rose from being 50th in 2020 to 19th in 2021 (1). Figure 1.9 Top 10 causes of death, by World Bank income group, in 2000, 2019, 2020 and 2021 COVID-19 Ischaemic heart disease Stroke Chronic obstructive pulmonary disease Lower respiratory infections Tuberculosis Diarrhoeal diseases Diabetes mellitus Cirrhosis of the liver Preterm birth complications HIV/AIDS Birth asphyxia and birth trauma Measles Road injury Note: Solid lines represent movement within the top 10 causes of death. Dashed lines represent movement in or out of the top 10 causes of death. Source: WHO (1). 1.3 Mortality-related SDG indicators The SDG framework includes several indicators on mortality pertaining to specific age groups, such as young children, and mortality due to specific causes (2). Overall progress has been observed for mortality-related SDG indicators; however, the current trends are not strong enough to reach the targets by 2030. 1.3.1 Maternal and child mortality Since the turn of the millennium, enhancing the health of mothers and children has been a top priority for global development. Maternal and child mortality reductions 14'\n",
            "    }\n",
            "  }, {\n",
            "    index=5,\n",
            "    score=0.9981756,\n",
            "    document={\n",
            "        _id='text-8',\n",
            "        chunk_text='This distribution of the leading 10 causes of death by broad cause group at global level remained unchanged from 2019 in 2020 and 2021; however, COVID-19 emerged as the third and second leading causes, respectively, claiming 4.1 million and 8.8 million lives globally. In all but two WHO regions (the African and Western Pacific regions), COVID-19 ranked among the top five causes of deaths in 2020 and 2021, responsible for the largest number of deaths in both years in the Region of the Americas, in 2021 in the South-East Asia Region and the second largest number of deaths in both years in the European and the Eastern Mediterranean regions. In the African Region, the disease only moved up from 12th to sixth in 2021. While in the Western Pacific Region it remained out of the top 10, it rose from being 50th in 2020 to 19th in 2021 (1). Figure 1.9 Top 10 causes of death, by World Bank income group, in 2000, 2019, 2020 and 2021 COVID-19 Ischaemic heart disease Stroke Chronic obstructive pulmonary disease Lower respiratory infections Tuberculosis Diarrhoeal diseases Diabetes mellitus Cirrhosis of the liver Preterm birth complications HIV/AIDS Birth asphyxia and birth trauma Measles Road injury Note: Solid lines represent movement within the top 10 causes of death. Dashed lines represent movement in or out of the top 10 causes of death. Source: WHO (1). 1.3 Mortality-related SDG indicators The SDG framework includes several indicators on mortality pertaining to specific age groups, such as young children, and mortality due to specific causes (2). Overall progress has been observed for mortality-related SDG indicators; however, the current trends are not strong enough to reach the targets by 2030. 1.3.1 Maternal and child mortality Since the turn of the millennium, enhancing the health of mothers and children has been a top priority for global development. Maternal and child mortality reductions 14'\n",
            "    }\n",
            "  }, {\n",
            "    index=6,\n",
            "    score=0.98986953,\n",
            "    document={\n",
            "        _id='text-6',\n",
            "        chunk_text='1.2.2 Leading causes of death Looking at the leading causes of death, there was also a clear transition from communicable causes to NCDs. Globally, five of the 10 leading causes in 2000 were communicable and four were NCDs, with road injury being the only injury cause (Fig. 1.7). In 2019, seven of the 10 leading causes were NCDs and the remaining three communicable (1). The pace of transition was uneven across regions and income groups. In 2019, communicable diseases continued to take up seven of the top 10 causes of deaths along with two NCDs and one injury in the African Region and low-income countries (1). With communicable diseases being effectively prevented or treated, and populations surviving to older ages where NCDs become the predominant risk, NCDs already accounted for nine of the top 10 causes in 2019 in the European Region and the Western Pacific Region (Fig. 1.8), as well as in upper-middle-income and high income countries (Fig. 1.9). The only communicable disease that ranked among the top 10 in these regions or income groups were lower respiratory infections (1). Figure 1.7 Top 10 causes of death globally in 2000, 2019, 2020 and 2021 Note: Solid lines represent movement within the top 10 causes of death. Dashed lines represent movement in or out of the top 10 causes of death. Source: WHO (1). 12'\n",
            "    }\n",
            "  }]\n"
          ]
        }
      ],
      "source": [
        "# print(docs)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "6DxuP-LPwGcC"
      },
      "outputs": [],
      "source": [
        "from typing import List, Any, Dict\n",
        "def serialize_top_docs(docs: List[Any], max_chars: int = 5000) -> str:\n",
        "    \"\"\"\n",
        "    Turn top docs into a short serialized block for the LLM.\n",
        "    Each doc includes a short id, page/content snippet and source metadata.\n",
        "    \"\"\"\n",
        "    pieces = []\n",
        "    for i, doc in enumerate(docs, start=1):\n",
        "        mid = doc.document.get(\"_id\")\n",
        "        # snip = (doc.page_content or \"\")[:max_chars].replace(\"\\n\", \" \")\n",
        "        snip = doc.document.get(\"chunk_text\").replace(\"\\n\", \" \")\n",
        "        pieces.append(f\"score={doc.score:.4f}| text={snip}\")\n",
        "    return \"\\n\\n\".join(pieces)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "64ZF6OgHuX9U"
      },
      "outputs": [],
      "source": [
        "from PIL import Image\n",
        "from google import genai\n",
        "from google.genai import types\n",
        "import csv\n",
        "\n",
        "ANSWER_PROMPT = \"\"\"\n",
        "\n",
        "Retrieved evidence:\n",
        "{retrieved_block}\n",
        "\n",
        "User question:\n",
        "{question}\n",
        "\n",
        "\"\"\"\n",
        "SYSTEM_INSTRUCTION = \"\"\"\n",
        "You are an evidence-based assistant. Use ONLY the retrieved evidence and the image provided to \\\n",
        "answer the user's question. Only provide factual answers.\n",
        "\n",
        "GUIDELINES:\n",
        "1) Produce a concise direct answer (1-3 sentences).\n",
        "Maintain conversation context across multiple turns\n",
        "2) Reference previous messages when relevant.\n",
        "3) Give more importance to texts that have high scores.\n",
        "4) Provide natural, engaging responses (not robotic)\n",
        "5) Appropriately cite figures/tables (e.g., \"As shown in Figure 5...\")\n",
        "6) Do NOT hallucinate facts not present in the retrieved texts.\n",
        "\"\"\"\n",
        "\n",
        "\n",
        "def generate_answer_from_retrieval(question: str, doc_texts:str, artifacts: List[str], image_dir:str) -> Dict[str, Any]:\n",
        "    retrieved_block = doc_texts\n",
        "    print(retrieved_block)\n",
        "    top_image = None\n",
        "    if len(artifacts) > 0:\n",
        "        top_image = artifacts[0]\n",
        "        # retrieved_block += f\"\\n\\nFigure {top_image['id']}: {top_image['metadata']['caption']}\"\n",
        "        image_filename = top_image['fields'].get('filename', '')\n",
        "        if image_filename.endswith('.png'):\n",
        "          im_data = Image.open(os.path.join(image_dir, image_filename))\n",
        "    prompt = ANSWER_PROMPT.format(retrieved_block=retrieved_block, question=question)\n",
        "    # print(prompt)\n",
        "    # call your LLM\n",
        "    response = client.models.generate_content(\n",
        "      model=LLM_MODEL_NAME,\n",
        "      config=types.GenerateContentConfig(\n",
        "        system_instruction=SYSTEM_INSTRUCTION),\n",
        "      contents=[prompt])\n",
        "    if top_image:\n",
        "      return response.text.strip(), top_image['_id']\n",
        "    return response.text.strip(), None"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "DTP1XfhSusMV"
      },
      "outputs": [],
      "source": [
        "import time\n",
        "import pandas as pd\n",
        "def build_submission(input_csv: str = \"266_lab2_questions.csv\",\n",
        "                     output_csv: str = \"submission.csv\"):\n",
        "    df = pd.read_csv(input_csv, sep=None, engine=\"python\")  # auto-detect sep\n",
        "    results = []\n",
        "\n",
        "    # keep per-conversation history\n",
        "    conv_hist = {}\n",
        "    try:\n",
        "      for ii, row in df.iterrows():\n",
        "          cid = row[\"conversation_id\"]\n",
        "          qid = row[\"id\"]\n",
        "          qnum = row[\"question_id\"]\n",
        "          question = row[\"question\"]\n",
        "          print(f\"Conversation id: {cid} Qid: {qid} Qnum: {qnum} Question: {question}\")\n",
        "          history = conv_hist.get(cid, [])\n",
        "          # retrieve\n",
        "          result_text, images = retrieve_context(question, history, img_threshold=0.0)\n",
        "          # print(f\"{images}\")\n",
        "          serialized_text = serialize_top_docs(result_text)\n",
        "          # generate answer using intelligent prompting\n",
        "          answer, fig_refs = generate_answer_from_retrieval(question, serialized_text, images, image_dir=\"./figures_method1\")\n",
        "\n",
        "          # answer = parsed.get(\"answer\", \"\").replace(\"\\n\", \" \").strip()\n",
        "          # fig_refs = parsed.get(\"figure_references\", \"0\")\n",
        "          print(f\"Answer: {answer}\")\n",
        "          # ensure '0' if empty\n",
        "          if not fig_refs:\n",
        "              fig_refs = \"0\"\n",
        "          else:\n",
        "              fig_refs = f\"Figure {fig_refs}\"\n",
        "\n",
        "          results.append({\n",
        "              \"id\": qid,\n",
        "              \"conversation_id\": cid,\n",
        "              \"question_id\": qnum,\n",
        "              \"answer\": answer,\n",
        "              \"figure_references\": fig_refs\n",
        "          })\n",
        "\n",
        "\n",
        "          # update history (you might also include the model answer if you want)\n",
        "          conv_hist.setdefault(cid, []).append(question)\n",
        "\n",
        "          # Use Rate-limiter 30s per question\n",
        "          print(\"Waiting 20s for next question\")\n",
        "          if ii < len(df) - 1: \n",
        "            time.sleep(20)\n",
        "    except Exception as e:\n",
        "      print(f\"Exception: {e}\")\n",
        "\n",
        "    finally:\n",
        "      # write CSV\n",
        "\n",
        "      with open(output_csv, \"w\", newline=\"\", encoding=\"utf-8\") as f:\n",
        "          writer = csv.DictWriter(f, fieldnames=[\"id\", \"conversation_id\", \"question_id\", \"answer\", \"figure_references\"])\n",
        "          writer.writeheader()\n",
        "          writer.writerows(results)\n",
        "\n",
        "      print(f\"Wrote {output_csv} ({len(results)} rows)\")"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "4xMLnvlNwyr3",
        "outputId": "3befe512-8b25-45f3-e095-a28ef5ae7c78"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "Conversation id: 1 Qid: 1 Qnum: 1 Question: What happened to global life expectancy during the COVID-19 pandemic?\n",
            "score=0.9973| text=Life expectancy, healthy life expectancy and burden of disease in the light of the COVID-19 pandemic However, the COVID-19 pandemic reversed this trend and wiped out the progress that was made in nearly a decade within just two years. Global life expectancy at birth dropped by 0.7 years to 72.5 (UI: 71.9–73.1) years in 2020 (back to the level of 2016), and by a further 1.1 years to 71.4 (UI: 70.8–72.0) years in 2021 (back to the level of 2012). Similarly, global HALE dropped to 62.8 (UI: 62.0– 63.7) years in 2020 (back to the level of 2016) and 61.9 (UI: 61.1–62.8) years in 2021 (back to the level of 2012) (1). The life expectancy at birth for both men and women dropped by about 1.7 years between 2019 and 2021. However, the decline for men was relatively more evenly split in 2020 (by 0.8 years) and 2021 (by 0.9 years), while the decline for women was concentrated more in 2021 (by 1.3 years) than in 2020 (by 0.5 years). Similar disparity between sexes was observed for HALE: HALE among men dropped by 0.7 years to 61.6 (UI: 60.9–62.4) years in 2020 and another 0.8 years to 60.9 (UI: 60.1–61.6) years in 2021, and HALE among women dropped by 0.5 years to 64.1 (UI: 63.2–65.0) years in 2020 and 1.1 years to 63.0 (UI: 62.2–63.9) years in 2021 (1). 1.1.2 Regional trends Prior to the pandemic, life expectancy and HALE had risen across all WHO regions and World Bank country income groups between 2000 and 2019 (Figs 1.2 and 1.3). The greatest gains were seen in low-resources settings including the African Region (11.2-year gain in life expectancy and 9.8-year gain in HALE) and the South-East Asia Region (7.3-year gain in life expectancy and 6.5- year gain in HALE); and in low-income countries (10.6- year gain in life expectancy and 9.3-year gain in HALE). Populations in high-income and upper-middle-income countries continue to live longer and healthier lives than those in low- and lower-middle-income countries. However, the pace of improvement in high-income countries has stagnated since 2010, with only a 1.1-year increase in life expectancy and a 0.6-year increase in HALE in 2010–2019, less than one third of the increases in low-income countries over the same period (1). Figure 1.2 Trends in life expectancy and HALE at birth, by sex and by WHO region, 2000–2021 Source: WHO (1). 7\n",
            "\n",
            "score=0.9972| text=Life expectancy, healthy life expectancy and burden of disease in the light of the COVID-19 pandemic However, the COVID-19 pandemic reversed this trend and wiped out the progress that was made in nearly a decade within just two years. Global life expectancy at birth dropped by 0.7 years to 72.5 (UI: 71.9–73.1) years in 2020 (back to the level of 2016), and by a further 1.1 years to 71.4 (UI: 70.8–72.0) years in 2021 (back to the level of 2012). Similarly, global HALE dropped to 62.8 (UI: 62.0– 63.7) years in 2020 (back to the level of 2016) and 61.9 (UI: 61.1–62.8) years in 2021 (back to the level of 2012) (1). The life expectancy at birth for both men and women dropped by about 1.7 years between 2019 and 2021. However, the decline for men was relatively more evenly split in 2020 (by 0.8 years) and 2021 (by 0.9 years), while the decline for women was concentrated more in 2021 (by 1.3 years) than in 2020 (by 0.5 years). Similar disparity between sexes was observed for HALE: HALE among men dropped by 0.7 years to 61.6 (UI: 60.9–62.4) years in 2020 and another 0.8 years to 60.9 (UI: 60.1–61.6) years in 2021, and HALE among women dropped by 0.5 years to 64.1 (UI: 63.2–65.0) years in 2020 and 1.1 years to 63.0 (UI: 62.2–63.9) years in 2021 (1). 1.1.2 Regional trends Prior to the pandemic, life expectancy and HALE had risen across all WHO regions and World Bank country income groups between 2000 and 2019 (Figs 1.2 and 1.3). The greatest gains were seen in low-resources settings including the African Region (11.2-year gain in life expectancy and 9.8-year gain in HALE) and the South-East Asia Region (7.3-year gain in life expectancy and 6.5- year gain in HALE); and in low-income countries (10.6- year gain in life expectancy and 9.3-year gain in HALE). Populations in high-income and upper-middle-income countries continue to live longer and healthier lives than those in low- and lower-middle-income countries. However, the pace of improvement in high-income countries has stagnated since 2010, with only a 1.1-year increase in life expectancy and a 0.6-year increase in HALE in 2010–2019, less than one third of the increases in low-income countries over the same period (1). Figure 1.2 Trends in life expectancy and HALE at birth, by sex and by WHO region, 2000–2021 Source: WHO (1). 7\n",
            "\n",
            "score=0.9906| text=1.1 Life expectancy and healthy life expectancy 1.1.1 Global trend Steady gain in global life expectancy at birth was observed from the turn of the millennium until the onset of the COVID-19 pandemic, up from 66.8 years (95% uncertainty interval1 [UI]: 66.2–67.3 years) in 2000 to 73.1 (UI: 72.6–73.7) years in 2019, with men gaining 6.2 years from 64.4 (UI: 63.9–64.9) years to 70.6 (UI 70.1–71.2) years and women gaining 6.5 years from 69.2 (UI: 68.7–69.8) years to 75.7 (UI: 75.3–76.2) years during this period. In parallel, global HALE at birth increased from 58.1 (UI: 57.4–58.9) years in 2000 to 63.5 (UI: 62.7– 64.3) years in 2019, with that for men increasing from 57.0 (UI: 56.3–57.6) years to 62.3 (UI: 61.7–63.1) years and that for women increasing from 59.3 (UI: 58.6–60.2) years to 64.6 (UI: 63.8–65.5) years (Fig. 1.1) (1). Figure 1.1 Global trends in life expectancy and HALE at birth, by sex, 2000–2021 Source: WHO (1). 1 Unless otherwise noted, the statistics quoted in this report are presented with 95% uncertainty intervals. 6\n",
            "Answer: During the COVID-19 pandemic, global life expectancy at birth saw a significant decline, reversing nearly a decade of progress within two years. It dropped by 0.7 years to 72.5 years in 2020, returning to 2016 levels, and then decreased by an additional 1.1 years to 71.4 years in 2021, which brought it back to 2012 levels.\n",
            "Waiting 5s for next question\n",
            "Conversation id: 1 Qid: 2 Qnum: 2 Question: Which regions were hit hardest by the pandemic?\n",
            "score=0.9934| text=Figure 1.3 Trends in life expectancy and HALE at birth, by sex and World Bank income group, 2000–2021 Source: WHO (1). In addition, the impact of the pandemic was unequal across regions and income groups. The Region of the Americas and the South-East Asia Region have been the hardest hit: life expectancy in both regions dropped by 3.0 years and HALE by 2.5 years between 2019 and 2021. The Western Pacific Region was the least affected during the first two years of the pandemic, with less than 0.1 years and 0.2 years of loss seen for life expectancy and HALE, respectively. It was the only WHO region in which increases in life expectancy (0.2-year gain) and HALE (0.1-year gain) were observed in 2020. However, the region experienced some losses (0.3 years in life expectancy and 0.3 years in HALE) in 2021 compared with 2020, that cancelled out the earlier gains (1). The scale of pandemic-related tolls also varied over time across regions. The Region of the Americas, the European Region and the Eastern Mediterranean Region all experienced more severe impact in the first pandemic year, with 2020 seeing at least two thirds of the life expectancy decline and three fifths of the HALE decline. In contrast, coinciding with the wider spread of the Delta variant, the decline in life expectancy and HALE in the African and South-East Asia regions occurred more predominantly in 2021, accounting for at least 65% of the total losses in 2019–2021 (Fig. 1.2) (1). By World Bank income groups, life expectancy was cut by 0.6 years in low-income countries and by 2.4 years in lower-middle-income countries, and HALE cut by 0.6 years and 2.0 years, respectively, between 2019 and 2021. Over half of the years lost in life expectancy and HALE in upper middle-income countries and over 70% of those in high income countries in 2019–2021 occurred during the first year of the pandemic. In lower-middle-income countries, the hardest hit occurred in 2021, seeing over 70% of the loss in life expectancy and HALE. In low-income countries, the worsening of longevity was rather minimal in 2020, associated with only 2% (0.01 of 0.55 years) of the decline in life expectancy (Fig. 1.3) (1). 8\n",
            "\n",
            "score=0.9796| text=Life expectancy, healthy life expectancy and burden of disease in the light of the COVID-19 pandemic However, the COVID-19 pandemic reversed this trend and wiped out the progress that was made in nearly a decade within just two years. Global life expectancy at birth dropped by 0.7 years to 72.5 (UI: 71.9–73.1) years in 2020 (back to the level of 2016), and by a further 1.1 years to 71.4 (UI: 70.8–72.0) years in 2021 (back to the level of 2012). Similarly, global HALE dropped to 62.8 (UI: 62.0– 63.7) years in 2020 (back to the level of 2016) and 61.9 (UI: 61.1–62.8) years in 2021 (back to the level of 2012) (1). The life expectancy at birth for both men and women dropped by about 1.7 years between 2019 and 2021. However, the decline for men was relatively more evenly split in 2020 (by 0.8 years) and 2021 (by 0.9 years), while the decline for women was concentrated more in 2021 (by 1.3 years) than in 2020 (by 0.5 years). Similar disparity between sexes was observed for HALE: HALE among men dropped by 0.7 years to 61.6 (UI: 60.9–62.4) years in 2020 and another 0.8 years to 60.9 (UI: 60.1–61.6) years in 2021, and HALE among women dropped by 0.5 years to 64.1 (UI: 63.2–65.0) years in 2020 and 1.1 years to 63.0 (UI: 62.2–63.9) years in 2021 (1). 1.1.2 Regional trends Prior to the pandemic, life expectancy and HALE had risen across all WHO regions and World Bank country income groups between 2000 and 2019 (Figs 1.2 and 1.3). The greatest gains were seen in low-resources settings including the African Region (11.2-year gain in life expectancy and 9.8-year gain in HALE) and the South-East Asia Region (7.3-year gain in life expectancy and 6.5- year gain in HALE); and in low-income countries (10.6- year gain in life expectancy and 9.3-year gain in HALE). Populations in high-income and upper-middle-income countries continue to live longer and healthier lives than those in low- and lower-middle-income countries. However, the pace of improvement in high-income countries has stagnated since 2010, with only a 1.1-year increase in life expectancy and a 0.6-year increase in HALE in 2010–2019, less than one third of the increases in low-income countries over the same period (1). Figure 1.2 Trends in life expectancy and HALE at birth, by sex and by WHO region, 2000–2021 Source: WHO (1). 7\n",
            "\n",
            "score=0.9794| text=Life expectancy, healthy life expectancy and burden of disease in the light of the COVID-19 pandemic However, the COVID-19 pandemic reversed this trend and wiped out the progress that was made in nearly a decade within just two years. Global life expectancy at birth dropped by 0.7 years to 72.5 (UI: 71.9–73.1) years in 2020 (back to the level of 2016), and by a further 1.1 years to 71.4 (UI: 70.8–72.0) years in 2021 (back to the level of 2012). Similarly, global HALE dropped to 62.8 (UI: 62.0– 63.7) years in 2020 (back to the level of 2016) and 61.9 (UI: 61.1–62.8) years in 2021 (back to the level of 2012) (1). The life expectancy at birth for both men and women dropped by about 1.7 years between 2019 and 2021. However, the decline for men was relatively more evenly split in 2020 (by 0.8 years) and 2021 (by 0.9 years), while the decline for women was concentrated more in 2021 (by 1.3 years) than in 2020 (by 0.5 years). Similar disparity between sexes was observed for HALE: HALE among men dropped by 0.7 years to 61.6 (UI: 60.9–62.4) years in 2020 and another 0.8 years to 60.9 (UI: 60.1–61.6) years in 2021, and HALE among women dropped by 0.5 years to 64.1 (UI: 63.2–65.0) years in 2020 and 1.1 years to 63.0 (UI: 62.2–63.9) years in 2021 (1). 1.1.2 Regional trends Prior to the pandemic, life expectancy and HALE had risen across all WHO regions and World Bank country income groups between 2000 and 2019 (Figs 1.2 and 1.3). The greatest gains were seen in low-resources settings including the African Region (11.2-year gain in life expectancy and 9.8-year gain in HALE) and the South-East Asia Region (7.3-year gain in life expectancy and 6.5- year gain in HALE); and in low-income countries (10.6- year gain in life expectancy and 9.3-year gain in HALE). Populations in high-income and upper-middle-income countries continue to live longer and healthier lives than those in low- and lower-middle-income countries. However, the pace of improvement in high-income countries has stagnated since 2010, with only a 1.1-year increase in life expectancy and a 0.6-year increase in HALE in 2010–2019, less than one third of the increases in low-income countries over the same period (1). Figure 1.2 Trends in life expectancy and HALE at birth, by sex and by WHO region, 2000–2021 Source: WHO (1). 7\n",
            "Answer: The Region of the Americas and the South-East Asia Region were the hardest hit by the pandemic, experiencing a 3.0-year drop in life expectancy and a 2.5-year drop in healthy life expectancy (HALE) between 2019 and 2021.\n",
            "Waiting 5s for next question\n",
            "Conversation id: 1 Qid: 3 Qnum: 3 Question: How did the disease burden shift during this time?\n",
            "score=0.9653| text=Among WHO regions, the African Region still had the largest share (54.9%) of deaths attributable to communicable diseases before the pandemic, with NCDs accounting for only about 36% of all deaths in 2019. These levels remained largely stable in 2020 and 2021, indicating little impact of the COVID-19 pandemic on the broad distribution of causes of death. Similarly, the Western Pacific Region has seen limited change since 2019 in the distribution across the three categories, with NCDs accounting for about 88% and communicable diseases for about 6% of all deaths (Fig. 1.5) (1). However, the pandemic has been more disruptive to the expected trajectories in other WHO regions. The European Region, which had the highest share of NCD deaths among all deaths in 2019 (89.6%), experienced an abrupt shift of disease burden back to communicable diseases in 2020 and 2021, as the share of NCD deaths dropped to 75.9% in 2021 and the share of communicable diseases nearly quadrupled from 5.3% in 2019 to 20.0% in 2021. Other WHO regions also experienced sizable, reversed shift of disease burden from NCDs and injuries back to communicable diseases, leading to increases in its share ranging from about 10% (Eastern Mediterranean Region) to 18% (South-East Asia Region) (1). Similar disparity was also observed across World Bank income groups (Fig. 1.6). Bearing the largest share (nearly 50%) of deaths due to communicable diseases, low income countries saw minimal change in the distribution of deaths from the three broad groups between 2019 and 2021. In contrast, NCDs in upper-middle-income and high income countries were responsible for the largest share of deaths at 84.8% and 88.1%, respectively, in 2019, but these figures dropped by 9.9% and 8.1% between 2019 and 2021 (1). Figure 1.5 Composition of causes of death, by WHO region, 2000–2021 Note: In countries that have low-quality vital registration, WHO’s current estimates include a cause of death category, “other pandemic-related mortality (OPRM)”, which could include underlying causes of deaths from any of the three groups. The graph only shows the relative composition of the three groups; OPRM is not included. Source: WHO (1). 10\n",
            "\n",
            "score=0.9651| text=Among WHO regions, the African Region still had the largest share (54.9%) of deaths attributable to communicable diseases before the pandemic, with NCDs accounting for only about 36% of all deaths in 2019. These levels remained largely stable in 2020 and 2021, indicating little impact of the COVID-19 pandemic on the broad distribution of causes of death. Similarly, the Western Pacific Region has seen limited change since 2019 in the distribution across the three categories, with NCDs accounting for about 88% and communicable diseases for about 6% of all deaths (Fig. 1.5) (1). However, the pandemic has been more disruptive to the expected trajectories in other WHO regions. The European Region, which had the highest share of NCD deaths among all deaths in 2019 (89.6%), experienced an abrupt shift of disease burden back to communicable diseases in 2020 and 2021, as the share of NCD deaths dropped to 75.9% in 2021 and the share of communicable diseases nearly quadrupled from 5.3% in 2019 to 20.0% in 2021. Other WHO regions also experienced sizable, reversed shift of disease burden from NCDs and injuries back to communicable diseases, leading to increases in its share ranging from about 10% (Eastern Mediterranean Region) to 18% (South-East Asia Region) (1). Similar disparity was also observed across World Bank income groups (Fig. 1.6). Bearing the largest share (nearly 50%) of deaths due to communicable diseases, low income countries saw minimal change in the distribution of deaths from the three broad groups between 2019 and 2021. In contrast, NCDs in upper-middle-income and high income countries were responsible for the largest share of deaths at 84.8% and 88.1%, respectively, in 2019, but these figures dropped by 9.9% and 8.1% between 2019 and 2021 (1). Figure 1.5 Composition of causes of death, by WHO region, 2000–2021 Note: In countries that have low-quality vital registration, WHO’s current estimates include a cause of death category, “other pandemic-related mortality (OPRM)”, which could include underlying causes of deaths from any of the three groups. The graph only shows the relative composition of the three groups; OPRM is not included. Source: WHO (1). 10\n",
            "\n",
            "score=0.9172| text=Life expectancy, healthy life expectancy and burden of disease 1.2 Shifting disease burden 1.2.1 Broad categories of causes of deaths Not only has the pandemic set back healthy longevity worldwide by years, it also reversed the previous trends of shifting disease burden to NCDs. Grouping deaths into three broad categories of causes of death – communicable, maternal, perinatal and nutritional conditions (“communicable diseases” hereafter), NCDs, and injuries – clear transition can be noticed well before the pandemic (1). Globally, NCDs accounted for 59.5% of all deaths in 2000, rising to 73.9% in 2019, while the share of communicable diseases dropped from 32.2% in 2000 to 18.2% in 2019, and injuries remained relatively stable around 8%. As COVID-19 emerged as a new infectious disease and started to take a toll on human lives, the share of deaths due to communicable diseases jumped back to the 2012 level (23.0%) in 2020 and further back to the 2005 level (28.1%) in 2021. Simultaneously, the share of NCD deaths dropped to 69.9% in 2020 and to 65.3% in 2021, and the share of injury deaths dropped to just about 7% in both years (Fig. 1.4) (1). Figure 1.4 Composition of causes of death, global, 2000–2021 Note: In countries that have low-quality vital registration, WHO’s current estimates include a cause of death category, “other pandemic-related mortality (OPRM)”, which could include underlying causes of deaths from any of the three groups. The graph only shows the relative composition of the three groups; OPRM is not included. Source: WHO (1). 9\n",
            "Answer: Globally, the disease burden shifted from a pre-pandemic trend of increasing non-communicable diseases (NCDs) to a rise in communicable diseases during 2020 and 2021, reaching levels similar to 2012 or 2005 (Fig. 1.4). While regions like the African and Western Pacific Regions saw little change, the European Region experienced an abrupt shift where the share of NCD deaths dropped from 89.6% in 2019 to 75.9% in 2021, and communicable diseases nearly quadrupled their share (Fig. 1.5). Similar shifts were observed in other WHO regions and in upper-middle and high-income countries.\n",
            "Waiting 5s for next question\n",
            "Conversation id: 2 Qid: 4 Qnum: 1 Question: What were the top causes of death globally in 2021?\n",
            "score=0.9976| text=This distribution of the leading 10 causes of death by broad cause group at global level remained unchanged from 2019 in 2020 and 2021; however, COVID-19 emerged as the third and second leading causes, respectively, claiming 4.1 million and 8.8 million lives globally. In all but two WHO regions (the African and Western Pacific regions), COVID-19 ranked among the top five causes of deaths in 2020 and 2021, responsible for the largest number of deaths in both years in the Region of the Americas, in 2021 in the South-East Asia Region and the second largest number of deaths in both years in the European and the Eastern Mediterranean regions. In the African Region, the disease only moved up from 12th to sixth in 2021. While in the Western Pacific Region it remained out of the top 10, it rose from being 50th in 2020 to 19th in 2021 (1). Figure 1.9 Top 10 causes of death, by World Bank income group, in 2000, 2019, 2020 and 2021 COVID-19 Ischaemic heart disease Stroke Chronic obstructive pulmonary disease Lower respiratory infections Tuberculosis Diarrhoeal diseases Diabetes mellitus Cirrhosis of the liver Preterm birth complications HIV/AIDS Birth asphyxia and birth trauma Measles Road injury Note: Solid lines represent movement within the top 10 causes of death. Dashed lines represent movement in or out of the top 10 causes of death. Source: WHO (1). 1.3 Mortality-related SDG indicators The SDG framework includes several indicators on mortality pertaining to specific age groups, such as young children, and mortality due to specific causes (2). Overall progress has been observed for mortality-related SDG indicators; however, the current trends are not strong enough to reach the targets by 2030. 1.3.1 Maternal and child mortality Since the turn of the millennium, enhancing the health of mothers and children has been a top priority for global development. Maternal and child mortality reductions 14\n",
            "\n",
            "score=0.9976| text=This distribution of the leading 10 causes of death by broad cause group at global level remained unchanged from 2019 in 2020 and 2021; however, COVID-19 emerged as the third and second leading causes, respectively, claiming 4.1 million and 8.8 million lives globally. In all but two WHO regions (the African and Western Pacific regions), COVID-19 ranked among the top five causes of deaths in 2020 and 2021, responsible for the largest number of deaths in both years in the Region of the Americas, in 2021 in the South-East Asia Region and the second largest number of deaths in both years in the European and the Eastern Mediterranean regions. In the African Region, the disease only moved up from 12th to sixth in 2021. While in the Western Pacific Region it remained out of the top 10, it rose from being 50th in 2020 to 19th in 2021 (1). Figure 1.9 Top 10 causes of death, by World Bank income group, in 2000, 2019, 2020 and 2021 COVID-19 Ischaemic heart disease Stroke Chronic obstructive pulmonary disease Lower respiratory infections Tuberculosis Diarrhoeal diseases Diabetes mellitus Cirrhosis of the liver Preterm birth complications HIV/AIDS Birth asphyxia and birth trauma Measles Road injury Note: Solid lines represent movement within the top 10 causes of death. Dashed lines represent movement in or out of the top 10 causes of death. Source: WHO (1). 1.3 Mortality-related SDG indicators The SDG framework includes several indicators on mortality pertaining to specific age groups, such as young children, and mortality due to specific causes (2). Overall progress has been observed for mortality-related SDG indicators; however, the current trends are not strong enough to reach the targets by 2030. 1.3.1 Maternal and child mortality Since the turn of the millennium, enhancing the health of mothers and children has been a top priority for global development. Maternal and child mortality reductions 14\n",
            "\n",
            "score=0.9885| text=1.2.2 Leading causes of death Looking at the leading causes of death, there was also a clear transition from communicable causes to NCDs. Globally, five of the 10 leading causes in 2000 were communicable and four were NCDs, with road injury being the only injury cause (Fig. 1.7). In 2019, seven of the 10 leading causes were NCDs and the remaining three communicable (1). The pace of transition was uneven across regions and income groups. In 2019, communicable diseases continued to take up seven of the top 10 causes of deaths along with two NCDs and one injury in the African Region and low-income countries (1). With communicable diseases being effectively prevented or treated, and populations surviving to older ages where NCDs become the predominant risk, NCDs already accounted for nine of the top 10 causes in 2019 in the European Region and the Western Pacific Region (Fig. 1.8), as well as in upper-middle-income and high income countries (Fig. 1.9). The only communicable disease that ranked among the top 10 in these regions or income groups were lower respiratory infections (1). Figure 1.7 Top 10 causes of death globally in 2000, 2019, 2020 and 2021 Note: Solid lines represent movement within the top 10 causes of death. Dashed lines represent movement in or out of the top 10 causes of death. Source: WHO (1). 12\n",
            "Answer: In 2021, the top causes of death globally included ischaemic heart disease, COVID-19, and stroke. COVID-19 emerged as the second leading cause of death globally in 2021, claiming 8.8 million lives (1).\n",
            "\n",
            "As shown in Figure 1.7, the top 10 causes of death globally in 2021 were:\n",
            "1. Ischaemic heart disease\n",
            "2. COVID-19\n",
            "3. Stroke\n",
            "4. Chronic obstructive pulmonary disease\n",
            "5. Lower respiratory infections\n",
            "6. Diabetes mellitus\n",
            "7. Alzheimer disease and other dementias\n",
            "8. Cirrhosis of the liver\n",
            "9. Diarrhoeal diseases\n",
            "10. Tuberculosis (1)\n",
            "Waiting 5s for next question\n",
            "Conversation id: 2 Qid: 5 Qnum: 2 Question: Did COVID-19 rank differently across regions?\n",
            "score=0.9660| text=This distribution of the leading 10 causes of death by broad cause group at global level remained unchanged from 2019 in 2020 and 2021; however, COVID-19 emerged as the third and second leading causes, respectively, claiming 4.1 million and 8.8 million lives globally. In all but two WHO regions (the African and Western Pacific regions), COVID-19 ranked among the top five causes of deaths in 2020 and 2021, responsible for the largest number of deaths in both years in the Region of the Americas, in 2021 in the South-East Asia Region and the second largest number of deaths in both years in the European and the Eastern Mediterranean regions. In the African Region, the disease only moved up from 12th to sixth in 2021. While in the Western Pacific Region it remained out of the top 10, it rose from being 50th in 2020 to 19th in 2021 (1). Figure 1.9 Top 10 causes of death, by World Bank income group, in 2000, 2019, 2020 and 2021 COVID-19 Ischaemic heart disease Stroke Chronic obstructive pulmonary disease Lower respiratory infections Tuberculosis Diarrhoeal diseases Diabetes mellitus Cirrhosis of the liver Preterm birth complications HIV/AIDS Birth asphyxia and birth trauma Measles Road injury Note: Solid lines represent movement within the top 10 causes of death. Dashed lines represent movement in or out of the top 10 causes of death. Source: WHO (1). 1.3 Mortality-related SDG indicators The SDG framework includes several indicators on mortality pertaining to specific age groups, such as young children, and mortality due to specific causes (2). Overall progress has been observed for mortality-related SDG indicators; however, the current trends are not strong enough to reach the targets by 2030. 1.3.1 Maternal and child mortality Since the turn of the millennium, enhancing the health of mothers and children has been a top priority for global development. Maternal and child mortality reductions 14\n",
            "\n",
            "score=0.9658| text=This distribution of the leading 10 causes of death by broad cause group at global level remained unchanged from 2019 in 2020 and 2021; however, COVID-19 emerged as the third and second leading causes, respectively, claiming 4.1 million and 8.8 million lives globally. In all but two WHO regions (the African and Western Pacific regions), COVID-19 ranked among the top five causes of deaths in 2020 and 2021, responsible for the largest number of deaths in both years in the Region of the Americas, in 2021 in the South-East Asia Region and the second largest number of deaths in both years in the European and the Eastern Mediterranean regions. In the African Region, the disease only moved up from 12th to sixth in 2021. While in the Western Pacific Region it remained out of the top 10, it rose from being 50th in 2020 to 19th in 2021 (1). Figure 1.9 Top 10 causes of death, by World Bank income group, in 2000, 2019, 2020 and 2021 COVID-19 Ischaemic heart disease Stroke Chronic obstructive pulmonary disease Lower respiratory infections Tuberculosis Diarrhoeal diseases Diabetes mellitus Cirrhosis of the liver Preterm birth complications HIV/AIDS Birth asphyxia and birth trauma Measles Road injury Note: Solid lines represent movement within the top 10 causes of death. Dashed lines represent movement in or out of the top 10 causes of death. Source: WHO (1). 1.3 Mortality-related SDG indicators The SDG framework includes several indicators on mortality pertaining to specific age groups, such as young children, and mortality due to specific causes (2). Overall progress has been observed for mortality-related SDG indicators; however, the current trends are not strong enough to reach the targets by 2030. 1.3.1 Maternal and child mortality Since the turn of the millennium, enhancing the health of mothers and children has been a top priority for global development. Maternal and child mortality reductions 14\n",
            "\n",
            "score=0.9649| text=Among WHO regions, the African Region still had the largest share (54.9%) of deaths attributable to communicable diseases before the pandemic, with NCDs accounting for only about 36% of all deaths in 2019. These levels remained largely stable in 2020 and 2021, indicating little impact of the COVID-19 pandemic on the broad distribution of causes of death. Similarly, the Western Pacific Region has seen limited change since 2019 in the distribution across the three categories, with NCDs accounting for about 88% and communicable diseases for about 6% of all deaths (Fig. 1.5) (1). However, the pandemic has been more disruptive to the expected trajectories in other WHO regions. The European Region, which had the highest share of NCD deaths among all deaths in 2019 (89.6%), experienced an abrupt shift of disease burden back to communicable diseases in 2020 and 2021, as the share of NCD deaths dropped to 75.9% in 2021 and the share of communicable diseases nearly quadrupled from 5.3% in 2019 to 20.0% in 2021. Other WHO regions also experienced sizable, reversed shift of disease burden from NCDs and injuries back to communicable diseases, leading to increases in its share ranging from about 10% (Eastern Mediterranean Region) to 18% (South-East Asia Region) (1). Similar disparity was also observed across World Bank income groups (Fig. 1.6). Bearing the largest share (nearly 50%) of deaths due to communicable diseases, low income countries saw minimal change in the distribution of deaths from the three broad groups between 2019 and 2021. In contrast, NCDs in upper-middle-income and high income countries were responsible for the largest share of deaths at 84.8% and 88.1%, respectively, in 2019, but these figures dropped by 9.9% and 8.1% between 2019 and 2021 (1). Figure 1.5 Composition of causes of death, by WHO region, 2000–2021 Note: In countries that have low-quality vital registration, WHO’s current estimates include a cause of death category, “other pandemic-related mortality (OPRM)”, which could include underlying causes of deaths from any of the three groups. The graph only shows the relative composition of the three groups; OPRM is not included. Source: WHO (1). 10\n",
            "Answer: Yes, COVID-19 ranked differently across various WHO regions. In 2020 and 2021, it was among the top five causes of death in all but two regions: the African and Western Pacific regions. Specifically, it was the leading cause of death in the Region of the Americas in both years, in the South-East Asia Region in 2021, and the second largest cause of death in the European and Eastern Mediterranean regions in both years. In the African Region, COVID-19 moved from 12th to sixth in 2021, while in the Western Pacific Region, it remained outside the top 10, rising from 50th in 2020 to 19th in 2021 (1).\n",
            "Waiting 5s for next question\n",
            "Conversation id: 2 Qid: 6 Qnum: 3 Question: What about child and maternal mortality during this period?\n",
            "score=0.9645| text=This distribution of the leading 10 causes of death by broad cause group at global level remained unchanged from 2019 in 2020 and 2021; however, COVID-19 emerged as the third and second leading causes, respectively, claiming 4.1 million and 8.8 million lives globally. In all but two WHO regions (the African and Western Pacific regions), COVID-19 ranked among the top five causes of deaths in 2020 and 2021, responsible for the largest number of deaths in both years in the Region of the Americas, in 2021 in the South-East Asia Region and the second largest number of deaths in both years in the European and the Eastern Mediterranean regions. In the African Region, the disease only moved up from 12th to sixth in 2021. While in the Western Pacific Region it remained out of the top 10, it rose from being 50th in 2020 to 19th in 2021 (1). Figure 1.9 Top 10 causes of death, by World Bank income group, in 2000, 2019, 2020 and 2021 COVID-19 Ischaemic heart disease Stroke Chronic obstructive pulmonary disease Lower respiratory infections Tuberculosis Diarrhoeal diseases Diabetes mellitus Cirrhosis of the liver Preterm birth complications HIV/AIDS Birth asphyxia and birth trauma Measles Road injury Note: Solid lines represent movement within the top 10 causes of death. Dashed lines represent movement in or out of the top 10 causes of death. Source: WHO (1). 1.3 Mortality-related SDG indicators The SDG framework includes several indicators on mortality pertaining to specific age groups, such as young children, and mortality due to specific causes (2). Overall progress has been observed for mortality-related SDG indicators; however, the current trends are not strong enough to reach the targets by 2030. 1.3.1 Maternal and child mortality Since the turn of the millennium, enhancing the health of mothers and children has been a top priority for global development. Maternal and child mortality reductions 14\n",
            "\n",
            "score=0.9641| text=This distribution of the leading 10 causes of death by broad cause group at global level remained unchanged from 2019 in 2020 and 2021; however, COVID-19 emerged as the third and second leading causes, respectively, claiming 4.1 million and 8.8 million lives globally. In all but two WHO regions (the African and Western Pacific regions), COVID-19 ranked among the top five causes of deaths in 2020 and 2021, responsible for the largest number of deaths in both years in the Region of the Americas, in 2021 in the South-East Asia Region and the second largest number of deaths in both years in the European and the Eastern Mediterranean regions. In the African Region, the disease only moved up from 12th to sixth in 2021. While in the Western Pacific Region it remained out of the top 10, it rose from being 50th in 2020 to 19th in 2021 (1). Figure 1.9 Top 10 causes of death, by World Bank income group, in 2000, 2019, 2020 and 2021 COVID-19 Ischaemic heart disease Stroke Chronic obstructive pulmonary disease Lower respiratory infections Tuberculosis Diarrhoeal diseases Diabetes mellitus Cirrhosis of the liver Preterm birth complications HIV/AIDS Birth asphyxia and birth trauma Measles Road injury Note: Solid lines represent movement within the top 10 causes of death. Dashed lines represent movement in or out of the top 10 causes of death. Source: WHO (1). 1.3 Mortality-related SDG indicators The SDG framework includes several indicators on mortality pertaining to specific age groups, such as young children, and mortality due to specific causes (2). Overall progress has been observed for mortality-related SDG indicators; however, the current trends are not strong enough to reach the targets by 2030. 1.3.1 Maternal and child mortality Since the turn of the millennium, enhancing the health of mothers and children has been a top priority for global development. Maternal and child mortality reductions 14\n",
            "\n",
            "score=0.9050| text=Life expectancy, healthy life expectancy and burden of disease in the light of the COVID-19 pandemic were among the Millennium Development Goals (MDGs), steering the global efforts through to the year 2015. They remain among the global targets in the SDG period, which runs from 2015 to 2030. Maternal mortality Marked reduction in maternal mortality was achieved during the MDG years between 2000 and 2015. The global maternal mortality ratio (MMR) (SDG indicator 3.1.1) dropped by a third from 339 (80% UI: 319–360) deaths per 100 000 live births in 2000 to 227 (80% UI: 211–246) deaths per 100 000 live births in 2015, equivalent to a 2.7% (80%, UI: 2.0–3.2%) average annual rate of reduction (ARR). However, progress has stagnated since, and the global MMR only dropped to 223 (80% UI: 202–255) deaths per 100 000 live births in 2020 as the ARR fell to –0.04% (80% UI: –1.6 to 1.1%) between 2016 and 2020 (Fig. 1.10). An estimated 287 000 (80% UI: 273 000–343 000) women globally died from a maternal cause in 2020, a number that remained unacceptably high and is equivalent to almost 800 deaths every day or one every two minutes (3). The African Region remained the region with the highest MMR throughout the two decades, despite a sustained decline with an ARR of 2%. The South-East Asia Region had experienced the steepest decline, reducing MMR from 372 (80% UI: 336–423) deaths per 100 000 live births in 2000 to 117 (80% UI: 106–133) deaths per 100 000 live births in 2020 and still maintaining an ARR at nearly 5% in the SDG era. Increasing MMRs were seen in the Region of the Americas, the European Region and Western Pacific Region between 2016 and 2020, despite the sizable decline during the MDG era. However, the levels of MMR have remained below 80 deaths per 100 000 live births in these three regions since 2000 (3). To achieve the SDG global target of MMR below 70 deaths per 100 000 live births by 2030, an ARR of 11.6% is required between 2021 and 2030, equivalent to over 1 million deaths averted, compared with a scenario where the 2016–2020 global stagnation continues (2, 3). Mortality among children under 5 years of age and among newborns Substantial global progress has been made in reducing childhood mortality since 2000. The total number of deaths among children under 5 years of age worldwide declined from 9.9 million (90% UI: 9.8–10.1 million) in 2000 to 4.9 million (90% UI: 4.6–5.4 million) in 2022, reflecting a 51% decline in the global under-five mortality rate (U5MR, SDG indicator 3.2.1) from 76 (90% UI: 75–78) deaths per 1000 live births in 2000 to 37 (90% UI: 35–41) deaths per 1000 live births in 2022 (4). Figure 1.10 Global MMR stratified by five-year time period, 2000–2020 R M M Period 2001–2005 2011–2015 Year 2006–2010 2016–2020 Shaded area indicates 80% uncertainty intervals. Source: WHO et al. (3). 15\n",
            "Answer: Substantial progress has been made in reducing maternal and child mortality since 2000. Global maternal mortality ratio (MMR) dropped by a third from 339 deaths per 100,000 live births in 2000 to 227 in 2015, although progress stagnated between 2016 and 2020, with 287,000 women dying from maternal causes in 2020 (3). Meanwhile, the total number of deaths among children under 5 years of age declined by 51%, from 9.9 million in 2000 to 4.9 million in 2022, with the global under-five mortality rate (U5MR) decreasing from 76 to 37 deaths per 1000 live births during the same period (4).\n",
            "Waiting 5s for next question\n",
            "Conversation id: 3 Qid: 7 Qnum: 1 Question: How is the world doing on HIV prevention?\n",
            "score=0.9349| text=2.1 Infectious diseases SDG target 3.3 advocates to end the epidemics of HIV/ AIDS, tuberculosis (TB), malaria and neglected tropical diseases (NTDs), and to combat hepatitis, waterborne diseases and other communicable diseases. This section describes the status of progress in the related SDG indicators along with that in combating polio and antimicrobial resistance (AMR). 2.1.1 HIV At the end of 2022, there were an estimated 39.0 million (UI: 33.1–45.7 million) people living with HIV globally, of which 37.5 million (UI: 31.8–43.6 million) were aged 15 years or older and 1.5 million (UI: 1.2–2.1 million) were children aged under 15 years (2). In 2022, there were 1.3 million (UI: 1.0–1.7 million) new HIV infections globally. This represents a 54% reduction from 2.8 million (UI: 2.2–3.8 million) in 2000, and 27% from 1.8 million (UI: 1.4–2.4 million) in 2015. The global HIV incidence rate (number of new HIV infections per 1000 uninfected population, SDG indicator 3.3.1) was 0.17 (UI: 0.13–0.23) in 2022, a 32% reduction from 0.25 (UI: 0.19–0.33) in 2015. However, progress varied across regions. The Eastern Mediterranean Region has seen a 45% increase in HIV incidence rate since 2015, although it still had the lowest number of new infections across WHO regions in 2022. HIV incidence rate declined by 31% during the same period in the South-East Asia Region, where both incidence rate and number are among the lowest. Despite impressive progress in reducing incidence, the African Region continued to bear the heaviest HIV burden (Fig. 2.1) (2, 3).1 Figure 2.1 Percentage change in the number of new HIV infections per 1000 uninfected population,a 2015–2022, and number of new HIV infections, 2022, globally and by WHO region Percentage change in HIV incidence rate was calculated from unrounded incidence rates. a Source: Joint United Nations Programme on HIV/AIDS (2, 3). 1 Percentage change in HIV incidence rate was calculated from unrounded incidence rates. 24\n",
            "\n",
            "score=0.9349| text=2.1 Infectious diseases SDG target 3.3 advocates to end the epidemics of HIV/ AIDS, tuberculosis (TB), malaria and neglected tropical diseases (NTDs), and to combat hepatitis, waterborne diseases and other communicable diseases. This section describes the status of progress in the related SDG indicators along with that in combating polio and antimicrobial resistance (AMR). 2.1.1 HIV At the end of 2022, there were an estimated 39.0 million (UI: 33.1–45.7 million) people living with HIV globally, of which 37.5 million (UI: 31.8–43.6 million) were aged 15 years or older and 1.5 million (UI: 1.2–2.1 million) were children aged under 15 years (2). In 2022, there were 1.3 million (UI: 1.0–1.7 million) new HIV infections globally. This represents a 54% reduction from 2.8 million (UI: 2.2–3.8 million) in 2000, and 27% from 1.8 million (UI: 1.4–2.4 million) in 2015. The global HIV incidence rate (number of new HIV infections per 1000 uninfected population, SDG indicator 3.3.1) was 0.17 (UI: 0.13–0.23) in 2022, a 32% reduction from 0.25 (UI: 0.19–0.33) in 2015. However, progress varied across regions. The Eastern Mediterranean Region has seen a 45% increase in HIV incidence rate since 2015, although it still had the lowest number of new infections across WHO regions in 2022. HIV incidence rate declined by 31% during the same period in the South-East Asia Region, where both incidence rate and number are among the lowest. Despite impressive progress in reducing incidence, the African Region continued to bear the heaviest HIV burden (Fig. 2.1) (2, 3).1 Figure 2.1 Percentage change in the number of new HIV infections per 1000 uninfected population,a 2015–2022, and number of new HIV infections, 2022, globally and by WHO region Percentage change in HIV incidence rate was calculated from unrounded incidence rates. a Source: Joint United Nations Programme on HIV/AIDS (2, 3). 1 Percentage change in HIV incidence rate was calculated from unrounded incidence rates. 24\n",
            "\n",
            "score=0.2524| text=Health-related SDGs Global initiatives call for curbing the number of new HIV infections to 370 000 in 2025 and 335 000 in 2030, equivalent to HIV incidence rates of 0.05 in 2025 and 0.025 in 2030 (4, 5). The latest estimates suggest that while the world is moving in the right direction, it is still far from reaching these targets. 2.1.2 TB An estimated 10.6 million (UI: 9.9–11.4 million) people developed TB globally in 2022, of which 55% were men, 33% were women and 12% were children under 15 years of age. The global TB incidence rate (SDG indicator 3.3.2) was 133 (UI: 124–143) per 100 000 population in 2022, down from 180 (UI: 134–233) per 100 000 population in 2000 and 146 (UI: 133–160) per 100 000 population in 2015. Figure 2.2 shows that TB incidence rates varied enormously across countries and areas in 2022 (6). The WHO End TB strategy calls for a 50% reduction of TB incidence rate by 2025 relative to the 2015 baseline, as a milestone towards the SDG 2030 and End TB 2035 targets (7). While TB incidence rate had continuously declined for many years up to 2020, two consecutive years of global increases in TB incidence (in 2021 and 2022) led to the TB incidence rate in 2022 reverting to the level of 2019. Globally, the net relative reduction in the TB incidence rate from 2015 to 2022 was 8.7%, falling far behind the WHO End TB strategy milestone (6). Nevertheless, there were encouraging signs of progress. The global trends in the number of people diagnosed with TB and treated showed a major recovery in 2022, after a sharp drop in 2020 due to the disruptions related to the COVID-19 pandemic (see section 2.3.1). Figure 2.2 TB incidence rate by country and area, 2022 Source: WHO (6). 25\n",
            "Answer: Globally, the world is moving in the right direction concerning HIV prevention, with new HIV infections reduced by 54% in 2022 compared to 2000, and the global HIV incidence rate declining by 32% since 2015. However, progress varies by region, and the world is still far from reaching the targets set for 2025 and 2030, which aim for an incidence rate of 0.05 and 0.025 respectively.\n",
            "Waiting 5s for next question\n",
            "Conversation id: 3 Qid: 8 Qnum: 2 Question: What about other infectious diseases like TB and malaria?\n",
            "score=0.3194| text=2.1.3 Malaria In 2022, there were an estimated 249 million (UI: 225– 278 million) malaria cases in 85 endemic countries and areas, leading to an estimated 631 000 (UI: 587 000– 747 000) deaths (8). The Global technical strategy for malaria 2016–2030 (GTS) calls for a reduction in malaria case incidence by at least 40% by 2020, 75% by 2025 and 90% by 2030 from a 2015 baseline, among other milestones and targets (9). The global malaria incidence rate (malaria cases per 1000 population at risk, SDG indicator 3.3.3) was 59.8 (UI: 54.8– 65.7) in 2015, having declined by 26% from 81.0 (UI: 75.7– 87.7) in 2000. The incidence rate continued to fall until 2019, before rising by 3% in 2020 and remaining stable since. In 2022, the incidence rate was 58.4 (UI: 52.9–65.3); the expected rate was 26.2 if it was on trajectory to reach GTS targets. If the current trends continue, it is unlikely that the GTS incidence targets will be achieved) (8). The WHO African Region continues to bear the heaviest burden of malaria. In 2022, the region accounted for 94% of global malaria cases and 95% of global malaria deaths. Children under the age of five are particularly vulnerable; in 2022, almost four in every five malaria deaths in the region were among these young children (8). WHO recently added the programmatic use of malaria vaccines for children living in endemic areas to the malaria prevention toolbox. The first malaria vaccine, RTS,S/AS01 (RTS,S), was recommended by WHO in 2021 after successful pilot programmes in Ghana, Kenya and Malawi through the Malaria Vaccine Implementation Programme (Box 2.1). In 2023, WHO recommended a second safe and effective malaria vaccine, R21-Matrix-M (R21) (10). Wide implementation of malaria vaccines is expected to save tens of thousands of lives each year. Box 2.1 Malaria vaccine implementation in Ghana, Kenya and Malawi The Malaria Vaccine Implementation Programme (MVIP) was established by WHO to evaluate the public health use of the first malaria vaccine, RTS,S/AS01 (10). Findings from the pilot programme informed the historic WHO recommendation in October 2021 for a vaccine to prevent malaria in children. Through the collaborative effort with the ministries of health in Ghana, Kenya and Malawi from 2019 to 2023, the RTS,S malaria vaccine was integrated into routine child immunization services as part of each country’s national malaria control programme. Over 2 million children received the RTS,S malaria vaccine through the pilot. Findings from MVIP show that the RTS,S vaccine substantially reduces early childhood deaths and hospitalizations for severe malaria. In October 2023, WHO recommended a second safe and effective malaria vaccine, R21, for routine use. This recommendation, resulting in sufficient vaccine supply to scale up malaria vaccines broadly, coupled with the high impact seen with the introduction of the RTS,S vaccine, underscores the potential of malaria vaccines as important interventions to act against Plasmodium falciparum, the deadliest malaria parasite globally and the most prevalent in Africa, and further supports the case for implementing the malaria vaccine as a routine child immunization. The wide-scale implementation of the malaria vaccines, which began in early 2024, holds the potential to save tens of thousands of lives each year. This is not just a scientific breakthrough but a life-saving intervention that can significantly reduce the burden of malaria on our communities. Key findings: substantial public health impact (11) Disease surveillance during 46 months of RTS,S vaccine use and scale-up, as part of the MVIP, showed that malaria vaccine introduction resulted in a 13% vaccine-attributable reduction in all-cause mortality (excluding injury) among children age-eligible for vaccination compared with children living in areas where the vaccine was not in use. Substantial reductions in severe malaria and malaria hospitalizations of children were also documented. Measured impact was additional to the benefits from insecticide-treated mosquito net (ITN) use and access to other child health interventions and care. 26\n",
            "\n",
            "score=0.3184| text=Health-related SDGs Global initiatives call for curbing the number of new HIV infections to 370 000 in 2025 and 335 000 in 2030, equivalent to HIV incidence rates of 0.05 in 2025 and 0.025 in 2030 (4, 5). The latest estimates suggest that while the world is moving in the right direction, it is still far from reaching these targets. 2.1.2 TB An estimated 10.6 million (UI: 9.9–11.4 million) people developed TB globally in 2022, of which 55% were men, 33% were women and 12% were children under 15 years of age. The global TB incidence rate (SDG indicator 3.3.2) was 133 (UI: 124–143) per 100 000 population in 2022, down from 180 (UI: 134–233) per 100 000 population in 2000 and 146 (UI: 133–160) per 100 000 population in 2015. Figure 2.2 shows that TB incidence rates varied enormously across countries and areas in 2022 (6). The WHO End TB strategy calls for a 50% reduction of TB incidence rate by 2025 relative to the 2015 baseline, as a milestone towards the SDG 2030 and End TB 2035 targets (7). While TB incidence rate had continuously declined for many years up to 2020, two consecutive years of global increases in TB incidence (in 2021 and 2022) led to the TB incidence rate in 2022 reverting to the level of 2019. Globally, the net relative reduction in the TB incidence rate from 2015 to 2022 was 8.7%, falling far behind the WHO End TB strategy milestone (6). Nevertheless, there were encouraging signs of progress. The global trends in the number of people diagnosed with TB and treated showed a major recovery in 2022, after a sharp drop in 2020 due to the disruptions related to the COVID-19 pandemic (see section 2.3.1). Figure 2.2 TB incidence rate by country and area, 2022 Source: WHO (6). 25\n",
            "\n",
            "score=0.3174| text=Health-related SDGs Global initiatives call for curbing the number of new HIV infections to 370 000 in 2025 and 335 000 in 2030, equivalent to HIV incidence rates of 0.05 in 2025 and 0.025 in 2030 (4, 5). The latest estimates suggest that while the world is moving in the right direction, it is still far from reaching these targets. 2.1.2 TB An estimated 10.6 million (UI: 9.9–11.4 million) people developed TB globally in 2022, of which 55% were men, 33% were women and 12% were children under 15 years of age. The global TB incidence rate (SDG indicator 3.3.2) was 133 (UI: 124–143) per 100 000 population in 2022, down from 180 (UI: 134–233) per 100 000 population in 2000 and 146 (UI: 133–160) per 100 000 population in 2015. Figure 2.2 shows that TB incidence rates varied enormously across countries and areas in 2022 (6). The WHO End TB strategy calls for a 50% reduction of TB incidence rate by 2025 relative to the 2015 baseline, as a milestone towards the SDG 2030 and End TB 2035 targets (7). While TB incidence rate had continuously declined for many years up to 2020, two consecutive years of global increases in TB incidence (in 2021 and 2022) led to the TB incidence rate in 2022 reverting to the level of 2019. Globally, the net relative reduction in the TB incidence rate from 2015 to 2022 was 8.7%, falling far behind the WHO End TB strategy milestone (6). Nevertheless, there were encouraging signs of progress. The global trends in the number of people diagnosed with TB and treated showed a major recovery in 2022, after a sharp drop in 2020 due to the disruptions related to the COVID-19 pandemic (see section 2.3.1). Figure 2.2 TB incidence rate by country and area, 2022 Source: WHO (6). 25\n",
            "Answer: In 2022, an estimated 10.6 million people globally developed Tuberculosis (TB), with a global incidence rate of 133 per 100,000 population. This rate showed increases in 2021 and 2022, reverting to 2019 levels and falling behind the WHO End TB strategy's 2025 milestone of a 50% reduction from the 2015 baseline.\n",
            "\n",
            "Regarding Malaria, there were an estimated 249 million cases and 631,000 deaths in 2022 across 85 endemic countries. The global malaria incidence rate was 58.4 in 2022, which is significantly higher than the expected rate of 26.2 needed to achieve the Global technical strategy for malaria 2016–2030 (GTS) targets. The WHO African Region continues to bear the heaviest burden, accounting for 94% of global malaria cases and 95% of deaths in 2022. Children under five remain particularly vulnerable. To combat this, WHO recommended the RTS,S/AS01 malaria vaccine in 2021 and the R21-Matrix-M vaccine in 2023, with wide implementation expected to save tens of thousands of lives annually.\n",
            "Waiting 5s for next question\n",
            "Conversation id: 3 Qid: 9 Qnum: 3 Question: Are there any success stories in disease elimination?\n",
            "score=0.2533| text=Box 2.2 Egypt becomes the first country to achieve the “gold tier” status on the path to elimination of hepatitis C In 2023, Egypt became the first country to achieve gold tier status on the path to eliminating hepatitis C in accordance with WHO criteria. This means that Egypt has fulfilled WHO’s targets that will set the country up to achieve the reduced incidence and mortality targets of full elimination before 2030. Egypt has implemented one of the world’s largest nationwide public health screening and treatment programmes for hepatitis C. Egypt had one of the highest rates of viral hepatitis in the world. Between the 1950s and 1980s, inadvertent infection transmission associated with unsafe injection practices occurred in the attempt to control schistosomiasis, a parasitic disease carried by water snails. Since the early 1990s, the government has put a huge effort into strengthening hepatitis prevention, with programmes covering blood safety, infection control and injection safety. It also worked on raising public awareness and running harm reduction programmes. Egypt launched a network of specialized treatment centres in 2006 and, with the new antiviral medicines discovered in 2014, hepatitis testing and treatment were made accessible and free of charge for everyone. In 2018, the government launched the presidential initiative “100 million seha” (100 million healthy lives), a massive and unprecedented nationwide campaign to detect and treat everyone with hepatitis C, escalating its elimination efforts. Through the campaign, everyone over 18 was tested, later expanding to children 12 years and older. In addition to routine testing at all health facilities, the campaign used outreach in the community, with teams visiting big squares, markets, workplaces, sports clubs, mosques and churches, and popular meeting places such as barbershops. Vulnerable communities such as refugees and migrants, and persons with disabilities were also included, to leave no one behind. Between 2018 and 2022, over 60 million people were tested with WHO-approved rapid diagnostic tests. Patients were also assessed and treated for other chronic diseases, such as hypertension and diabetes. A total of 4.1 million received treatment for hepatitis C with locally manufactured medicines between 2014 and 2022, of which 98% were virally suppressed. Expanding direct public health approaches to community prevention, testing and treatment, as shown by Egypt’s successful public health programme to eliminate hepatitis C, can have a population-wide impact. A case study concluded that five key elements contributed to Egypt’s successful programme: the availability of sufficient and reliable epidemiological data; a robust public health care infrastructure; inclusive care that reached all sectors of society; political commitment with increased health-care spending and a comprehensive long-term strategy for viral hepatitis; and use of innovation and information technology (14). Source: WHO (15). 30\n",
            "\n",
            "score=0.2518| text=Box 2.2 Egypt becomes the first country to achieve the “gold tier” status on the path to elimination of hepatitis C In 2023, Egypt became the first country to achieve gold tier status on the path to eliminating hepatitis C in accordance with WHO criteria. This means that Egypt has fulfilled WHO’s targets that will set the country up to achieve the reduced incidence and mortality targets of full elimination before 2030. Egypt has implemented one of the world’s largest nationwide public health screening and treatment programmes for hepatitis C. Egypt had one of the highest rates of viral hepatitis in the world. Between the 1950s and 1980s, inadvertent infection transmission associated with unsafe injection practices occurred in the attempt to control schistosomiasis, a parasitic disease carried by water snails. Since the early 1990s, the government has put a huge effort into strengthening hepatitis prevention, with programmes covering blood safety, infection control and injection safety. It also worked on raising public awareness and running harm reduction programmes. Egypt launched a network of specialized treatment centres in 2006 and, with the new antiviral medicines discovered in 2014, hepatitis testing and treatment were made accessible and free of charge for everyone. In 2018, the government launched the presidential initiative “100 million seha” (100 million healthy lives), a massive and unprecedented nationwide campaign to detect and treat everyone with hepatitis C, escalating its elimination efforts. Through the campaign, everyone over 18 was tested, later expanding to children 12 years and older. In addition to routine testing at all health facilities, the campaign used outreach in the community, with teams visiting big squares, markets, workplaces, sports clubs, mosques and churches, and popular meeting places such as barbershops. Vulnerable communities such as refugees and migrants, and persons with disabilities were also included, to leave no one behind. Between 2018 and 2022, over 60 million people were tested with WHO-approved rapid diagnostic tests. Patients were also assessed and treated for other chronic diseases, such as hypertension and diabetes. A total of 4.1 million received treatment for hepatitis C with locally manufactured medicines between 2014 and 2022, of which 98% were virally suppressed. Expanding direct public health approaches to community prevention, testing and treatment, as shown by Egypt’s successful public health programme to eliminate hepatitis C, can have a population-wide impact. A case study concluded that five key elements contributed to Egypt’s successful programme: the availability of sufficient and reliable epidemiological data; a robust public health care infrastructure; inclusive care that reached all sectors of society; political commitment with increased health-care spending and a comprehensive long-term strategy for viral hepatitis; and use of innovation and information technology (14). Source: WHO (15). 30\n",
            "\n",
            "score=0.1361| text=Box 2.3 Bangladesh eliminates visceral leishmaniasis and lymphatic filariasis as a public health problem In 2023, Bangladesh became the first country globally to be validated for elimination of visceral leishmaniasis, also called kala azar, as a public health problem. The country achieved the elimination target of less than one case per 10 000 population at the sub-district (upazila) level in 2017 and has sustained it to date despite disruptions related to the COVID-19 pandemic. In 2005, Bangladesh, together with India and Nepal, launched a Regional Kala-azar Elimination Initiative with the aim of wiping out the disease. The Government of Bangladesh, WHO, the Special Programme for Research and Training in Tropical Diseases (TDR) and several other partners supported research and development of new diagnostic tools, effective treatments and vector control (especially indoor residual spraying), and facilitated their roll-out and access by all those in need through donation programmes, which helped the country meet the criteria set by WHO for elimination as a public health problem (18). Kala azar is the most severe form of leishmaniasis and is transmitted by sandflies; it is commonly prevalent among the most disadvantaged rural communities. The disease leads to symptoms such as fever, weight loss, and spleen and liver enlargement and, if left untreated, can prove fatal in over 95% of cases. In 2023, Bangladesh was also validated as the fourth country in the WHO South-East Asia Region to eliminate lymphatic filariasis as a public health problem, after Maldives, Sri Lanka and Thailand. Lymphatic filariasis, also known as elephantiasis, occurs when filarial parasites are transmitted to humans through mosquito bites. The infection is usually acquired in childhood with painful and disfiguring visible manifestations appearing much later in life, often in the form of enlargement of body parts, causing pain, severe disability and associated stigma. Lymphatic filariasis was a major public health problem in Bangladesh and was endemic in 19 of its 64 districts. In 2001, the country established a national elimination programme. Between 2001 and 2015, high-coverage mass drug administration campaigns were carried out in all endemic districts. A series of transmission assessment surveys was carried out by programme personnel between 2011 and 2021, which demonstrated that transmission levels were below the threshold established by WHO for elimination as a public health problem. To meet WHO’s validation criteria on morbidity management and disability prevention (19), Bangladesh also strengthened access to the recommended essential package of care in all endemic districts. Notably, over 31 000 people affected by lymphatic filariasis have been trained in self-care and provided with kits to manage their disease condition and improve their quality of life. For both kala azar and lymphatic filariasis, Bangladesh will now focus on post-validation surveillance to sustain its hard-won status and prevent recurrence of infection. Source: WHO (20, 21). 32\n",
            "Answer: Yes, there are indeed success stories in disease elimination.\n",
            "\n",
            "In 2023, Egypt became the first country to achieve \"gold tier\" status on the path to eliminating hepatitis C, fulfilling WHO targets for reduced incidence and mortality before 2030 through a massive nationwide screening and treatment program. Additionally, Bangladesh successfully eliminated visceral leishmaniasis and lymphatic filariasis as public health problems in the same year, following comprehensive national and regional initiatives.\n",
            "Waiting 5s for next question\n",
            "Conversation id: 4 Qid: 10 Qnum: 1 Question: What's the status of tobacco and alcohol consumption globally?\n",
            "score=0.9567| text=The Netherlands (Kingdom of the) has a long history of tobacco control dating back to the 1950s. In more recent times, some examples of measures adopted in line with the WHO Framework Convention on Tobacco Control include (34): 2005: Netherlands (Kingdom of the) became a Party to the WHO Framework Convention on Tobacco Control. 2008: Extension of a smoking ban to the hospitality sector (with some exceptions). 2014: Rise in the legal age for purchase of tobacco from 16 to 18 years of age. 2016: Implementation of EU Tobacco Products Directive II, restricting the use of flavourings and dangerous additives, and adding pictorial health warnings on tobacco packs. Establishment of a new, toll-free national quit-smoking line. 2018: Signing of National Prevention Agreement (NPA) by the government and 70 organizations to address tobacco use (among other risk factors), with the aim that, by 2040, the country would have less than 5% of its population as smokers, and no children or pregnant women smoking. 2019: Adoption of the NPA by the House of Representatives. Amendment to the Tobacco Act to include a ban on the display of tobacco products at point of sale, except inside specialized tobacconists, with different steps and transitional periods until mid-2022. 2020: Netherlands (Kingdom of the) became a Party to the Protocol to Eliminate Illicit Trade in Tobacco Products. Implementation of plain packaging and a ban on tobacco vending machines. 2021: Closing of long-standing tobacco control gaps, such as banning advertising of tobacco products at points of sale and allowing no designated smoking rooms in public places, workplaces and public transport. Over recent years, the Netherlands (Kingdom of the) has increased excise tax on tobacco products, which has led to real price increases over time (14% above inflation over the past 10 years). In 2022, total taxes represented close to 77% of the retail price of the most sold brand. In the 2023 WHO report on the global tobacco epidemic, the Netherlands (Kingdom of the) is featured as one of only four countries in the world that have attained best-practice level adoption of all MPOWER measures – WHO’s technical package that assists countries to implement the evidence-based demand-reduction measures of the WHO Framework Convention on Tobacco Control (34). Alcohol consumption SDG indicator 3.5.2 is defined as total (recorded and unrecorded) alcohol per capita consumption (APC) per year, adjusted for tourist consumption, in persons aged 15 years and older, measured in litres of pure alcohol. Globally in 2019, the total APC stood at 5.5 litres (UI: 4.8–6.2), a 4.5% decline from 5.7 litres (UI: 5.1–6.4) in 2010 (35). Comparing this pace of decline with the global targets of at least 10% reduction by 2025 and at least 20% by 2030, it is evident that acceleration is needed (31, 36, 37). Moreover, the 2019 global APC was still higher than the 2000 level (5.1 litres, UI: 4.6–5.6) (35). Despite consistent reduction since 2000, including 9.8% reduction since 2010, the European Region continued to have the highest total APC. The South-East Asia Region is the only region where total APC has continuously increased, although the rise has considerably slowed since 2010. Total APC remained very low in the Eastern Mediterranean Region, with total APC of 0.3 litres (UI: 0.2–0.5) in 2019. As with tobacco use, globally alcohol consumption among men has been consistently higher than among women. Box 2.5 presents an analysis of sex related inequalities in alcohol consumption globally and by WHO region (35). The COVID-19 pandemic had an apparent impact on alcohol consumption globally, although its magnitude and duration remain to be reliably defined. The preliminary global estimate for total APC in 2020 is 4.9 litres (UI: 4.3–5.6) (38). 36\n",
            "\n",
            "score=0.9562| text=The Netherlands (Kingdom of the) has a long history of tobacco control dating back to the 1950s. In more recent times, some examples of measures adopted in line with the WHO Framework Convention on Tobacco Control include (34): 2005: Netherlands (Kingdom of the) became a Party to the WHO Framework Convention on Tobacco Control. 2008: Extension of a smoking ban to the hospitality sector (with some exceptions). 2014: Rise in the legal age for purchase of tobacco from 16 to 18 years of age. 2016: Implementation of EU Tobacco Products Directive II, restricting the use of flavourings and dangerous additives, and adding pictorial health warnings on tobacco packs. Establishment of a new, toll-free national quit-smoking line. 2018: Signing of National Prevention Agreement (NPA) by the government and 70 organizations to address tobacco use (among other risk factors), with the aim that, by 2040, the country would have less than 5% of its population as smokers, and no children or pregnant women smoking. 2019: Adoption of the NPA by the House of Representatives. Amendment to the Tobacco Act to include a ban on the display of tobacco products at point of sale, except inside specialized tobacconists, with different steps and transitional periods until mid-2022. 2020: Netherlands (Kingdom of the) became a Party to the Protocol to Eliminate Illicit Trade in Tobacco Products. Implementation of plain packaging and a ban on tobacco vending machines. 2021: Closing of long-standing tobacco control gaps, such as banning advertising of tobacco products at points of sale and allowing no designated smoking rooms in public places, workplaces and public transport. Over recent years, the Netherlands (Kingdom of the) has increased excise tax on tobacco products, which has led to real price increases over time (14% above inflation over the past 10 years). In 2022, total taxes represented close to 77% of the retail price of the most sold brand. In the 2023 WHO report on the global tobacco epidemic, the Netherlands (Kingdom of the) is featured as one of only four countries in the world that have attained best-practice level adoption of all MPOWER measures – WHO’s technical package that assists countries to implement the evidence-based demand-reduction measures of the WHO Framework Convention on Tobacco Control (34). Alcohol consumption SDG indicator 3.5.2 is defined as total (recorded and unrecorded) alcohol per capita consumption (APC) per year, adjusted for tourist consumption, in persons aged 15 years and older, measured in litres of pure alcohol. Globally in 2019, the total APC stood at 5.5 litres (UI: 4.8–6.2), a 4.5% decline from 5.7 litres (UI: 5.1–6.4) in 2010 (35). Comparing this pace of decline with the global targets of at least 10% reduction by 2025 and at least 20% by 2030, it is evident that acceleration is needed (31, 36, 37). Moreover, the 2019 global APC was still higher than the 2000 level (5.1 litres, UI: 4.6–5.6) (35). Despite consistent reduction since 2000, including 9.8% reduction since 2010, the European Region continued to have the highest total APC. The South-East Asia Region is the only region where total APC has continuously increased, although the rise has considerably slowed since 2010. Total APC remained very low in the Eastern Mediterranean Region, with total APC of 0.3 litres (UI: 0.2–0.5) in 2019. As with tobacco use, globally alcohol consumption among men has been consistently higher than among women. Box 2.5 presents an analysis of sex related inequalities in alcohol consumption globally and by WHO region (35). The COVID-19 pandemic had an apparent impact on alcohol consumption globally, although its magnitude and duration remain to be reliably defined. The preliminary global estimate for total APC in 2020 is 4.9 litres (UI: 4.3–5.6) (38). 36\n",
            "\n",
            "score=0.6376| text=2.2 Risk factors for health Many factors affect the health of individuals and communities. A risk factor for health is any attribute, characteristic or exposure of an individual that increases their likelihood of developing a disease or injury. This section presents progress towards achieving SDG and GPW13 targets related to several risk factors for health. 2.2.1 Nutritional risk factors Better nutrition is related to improved infant, child and maternal health, stronger immune systems, lower risk of NCDs, and longevity. Today, the world faces the multiple burden of malnutrition that comprises undernutrition, overweight (including obesity) and micronutrient deficiencies. Section 4.1 discusses the global trends in undernutrition and overweight or obesity. This section summarizes the global progress towards the reduction of anaemia among women and the consumption of trans-fatty acids (TFA). Anaemia among women Women with anaemia are more likely to experience fatigue and impaired physical capacity in their daily lives. Moderate and severe anaemia are also risk factors for adverse maternal and perinatal outcomes. Global trends in the prevalence of anaemia among all women 15–49 years of age (SDG indicator 2.2.3) show no significant change from 31.2% (UI: 28.7–34.1) in 2000 to 29.9% (UI: 27.0–32.8) in 2019. With population growth, the total number of women aged 15–49 years affected increased from 493 million in 2000 to 571 million in 2019. While there was a slight decrease in anaemia prevalence among pregnant women from 40.9% (UI: 38.7–43.1) in 2000 to 36.5% (UI: 34.0–39.1) in 2019, prevalence among non-pregnant women remained stagnant, at 30.7% (UI: 28.1–33.7) in 2000 and 29.6% (UI: 26.6–32.5) in 2019 (27). Across WHO regions, the decline in anaemia prevalence among women observed during the MDG era either halted or slowed after 2015. This latest evidence suggests that the global target of 50% reduction of anaemia in women of reproductive age by 2025 (from a 2012 baseline) is unlikely to be met (27, 28). Trans-fatty acids Intake of TFA is associated with increased risk of heart attacks and death from coronary heart disease. WHO designated TFA elimination as one of its priority targets in 2018, calling for the global elimination of industrially produced TFA by 2023. Mandatory TFA policies are currently in effect in 69 countries in all WHO regions, covering 55% of the global population (4.4 billion people). Of these countries, 53 have “best-practice” policies, which include mandatory national limit of 2 g of industrially produced TFA per 100 g of total fat in all foods and mandatory national ban on the production or use of partially hydrogenated oils as an ingredient in all foods. Population coverage by best-practice TFA policies has grown considerably. In 2018, best-practice policies were in effect for just 6% of the global population (480 million people). By the end of 2023, this has increased to 46% coverage (3.7 billion people) (29). However, accelerated actions are needed to meet the target of 100% global population coverage (30). 2.2.2 Behavioural risk factors Modifiable behaviours such as tobacco use, alcohol consumption, physical inactivity and an unhealthy diet are among the known risk factors associated with NCDs. This section summarizes the global progress towards the reduction of tobacco use and alcohol consumption. Tobacco use The Global action plan for the prevention and control of NCDs 2013–2020, which has been extended until 2030, includes a target for reducing the global prevalence of tobacco use by 30% by the year 2025, relative to 2010 (31, 32). In 2022, the global age-standardized prevalence of current tobacco use among persons aged 15 years and older (SDG indicator 3.a.1) was estimated at 20.9% (UI: 18.8–22.9), a 21% relative decline from 26.4% in 2010. If current trends continue, the world will see a 25% relative reduction in prevalence by 2025. While this is short of the 30% reduction target, progress is encouraging as tobacco use has been declining in all WHO regions. The South-East Asia Region, having consistently the highest prevalence since 2000, is projected to achieve a 34% reduction by 2025 relative to 2010. The African Region is expected to reach a 32% relative reduction by 2025 and remain the region with the lowest prevalence. The European Region, in contrast, is projected to have the highest prevalence across all WHO regions in 2030 at 23.1% (33). Owing to its long history of tobacco control, the 34\n",
            "Answer: Globally, the age-standardized prevalence of current tobacco use among persons aged 15 years and older was estimated at 20.9% in 2022, representing a 21% relative decline from 26.4% in 2010. While this progress is encouraging, the world is projected to achieve a 25% relative reduction by 2025, falling short of the 30% reduction target.\n",
            "\n",
            "For alcohol, the total alcohol per capita consumption (APC) globally in 2019 was 5.5 litres, a 4.5% decline from 5.7 litres in 2010, but still higher than the 2000 level of 5.1 litres. This pace of decline indicates that acceleration is needed to meet global targets of at least 10% reduction by 2025 and 20% by 2030. Preliminary global estimates suggest total APC in 2020 was 4.9 litres, with the COVID-19 pandemic having an apparent impact on consumption.\n",
            "Waiting 5s for next question\n",
            "Conversation id: 4 Qid: 11 Qnum: 2 Question: Are people getting better access to clean water and sanitation?\n",
            "score=0.8607| text=2.2.3 Metabolic risk factors Metabolic risk factors for NCDs include hypertension, overweight and obesity, high blood glucose levels and high levels of fat in the blood. This section summarizes the global progress towards the reduction of hypertension; overweight and obesity are discussed in section 4.1. Hypertension For the purpose of monitoring population health, hypertension is defined as having raised blood pressure4 or taking medication for hypertension. The age-standardized prevalence of hypertension among adults aged 30–79 has changed little in the past three decades globally and in all WHO regions, with a notable exception in the European Region, where there has been a continuous decline. In 2019, the global prevalence stood at 33.1% (UI: 31.5–34.8%), and slightly higher among men (34.5%; UI: 32.0–36.9%) than women (31.7%; UI: 29.6–33.9%). However, available data suggests a higher treatment coverage among women globally, leading to a higher prevalence of controlled hypertension than for men (Box 2.6) (39). The voluntary global target on blood pressure envisages a 25% reduction in raised blood pressure (uncontrolled hypertension) by 2025 against a 2010 baseline (31, 32). Globally, the age-standardized prevalence of uncontrolled hypertension declined slightly from 28.6% (UI: 28.0– 29.3%) in 2010 to 26.2% (UI: 24.7–27.8%) in 2019, but this pace of decline is insufficient to achieve the global target by 2025 (39). 2.2.4 Environmental risk factors Human health is dependent on a variety of environmental factors, such as safe WASH, clean air, safe chemical use, healthy built environments, sound agricultural practices, and protected natural areas and water sources. This section outlines the global progress towards universal access to WASH and the reduction of air pollution. Trends in mortality attributable to environmental risk factors are discussed in Chapter 1. WASH Between 2000 and 2022, worldwide some 2.1 billion people gained access to safely managed drinking water (687 million increase since 2015) and 2.5 billion people gained access to safely managed sanitation (902 million increase since 2015). Since 2015, the number of people with basic hygiene services has increased by over 1 billion. Access to safe WASH services improved significantly in rural areas between 2015 and 2022, but progress is limited in urban areas, when measured by the proportion of the population gaining services. However, because of population growth in urban areas, the number of people who have gained access to safely managed drinking water and sanitation services since 2015 is higher in urban than in rural areas (Fig. 2.9) (40). Box 2.6 Global sex-related inequalities in hypertension Globally, there are sex-related inequalities in age-standardized prevalence of hypertension among adults aged 30–79 years. While there was no sex-related inequality in 1990 (prevalence of 32.4% [UI: 29.9–35.0] among men and 32.2% [UI: 29.7–34.9] among women), hypertension prevalence was slightly higher among men (34.5%; UI: 32.0–36.9) than women (31.7%; UI: 29.6–33.9) in 2019 (Fig. 2.8). Age-standardized coverage of treatment for hypertension among adults aged 30–79 years with hypertension largely increased between 1990 and 2019, with the pace of increase slowing down slightly during the past decade, among both men and women. In contrast to hypertension prevalence, which was 2.8 percentage points higher among men than women in 2019, treatment prevalence was 9.3 percentage points higher among women (47.2%; UI: 43.4–50.9) than men (37.9%; UI: 34.5–41.1) in 2019. Consequently, age-standardized prevalence of controlled hypertension among adults aged 30–79 years with hypertension also increased between 1990 and 2019, with faster improvements among women than men, leading to an increase in sex-related absolute inequality over time. In 2019, controlled hypertension prevalence was 5.1 percentage points higher among women (23.5%; UI: 20.4–26.9) than men (18.4%; UI: 15.9–21.2). 4 Defined as systolic blood pressure (SBP) ≥ 140 mmHg or diastolic blood pressure (DBP) ≥ 90 mmHg, regardless of diagnosis or medication status. 38\n",
            "\n",
            "score=0.8601| text=2.2.3 Metabolic risk factors Metabolic risk factors for NCDs include hypertension, overweight and obesity, high blood glucose levels and high levels of fat in the blood. This section summarizes the global progress towards the reduction of hypertension; overweight and obesity are discussed in section 4.1. Hypertension For the purpose of monitoring population health, hypertension is defined as having raised blood pressure4 or taking medication for hypertension. The age-standardized prevalence of hypertension among adults aged 30–79 has changed little in the past three decades globally and in all WHO regions, with a notable exception in the European Region, where there has been a continuous decline. In 2019, the global prevalence stood at 33.1% (UI: 31.5–34.8%), and slightly higher among men (34.5%; UI: 32.0–36.9%) than women (31.7%; UI: 29.6–33.9%). However, available data suggests a higher treatment coverage among women globally, leading to a higher prevalence of controlled hypertension than for men (Box 2.6) (39). The voluntary global target on blood pressure envisages a 25% reduction in raised blood pressure (uncontrolled hypertension) by 2025 against a 2010 baseline (31, 32). Globally, the age-standardized prevalence of uncontrolled hypertension declined slightly from 28.6% (UI: 28.0– 29.3%) in 2010 to 26.2% (UI: 24.7–27.8%) in 2019, but this pace of decline is insufficient to achieve the global target by 2025 (39). 2.2.4 Environmental risk factors Human health is dependent on a variety of environmental factors, such as safe WASH, clean air, safe chemical use, healthy built environments, sound agricultural practices, and protected natural areas and water sources. This section outlines the global progress towards universal access to WASH and the reduction of air pollution. Trends in mortality attributable to environmental risk factors are discussed in Chapter 1. WASH Between 2000 and 2022, worldwide some 2.1 billion people gained access to safely managed drinking water (687 million increase since 2015) and 2.5 billion people gained access to safely managed sanitation (902 million increase since 2015). Since 2015, the number of people with basic hygiene services has increased by over 1 billion. Access to safe WASH services improved significantly in rural areas between 2015 and 2022, but progress is limited in urban areas, when measured by the proportion of the population gaining services. However, because of population growth in urban areas, the number of people who have gained access to safely managed drinking water and sanitation services since 2015 is higher in urban than in rural areas (Fig. 2.9) (40). Box 2.6 Global sex-related inequalities in hypertension Globally, there are sex-related inequalities in age-standardized prevalence of hypertension among adults aged 30–79 years. While there was no sex-related inequality in 1990 (prevalence of 32.4% [UI: 29.9–35.0] among men and 32.2% [UI: 29.7–34.9] among women), hypertension prevalence was slightly higher among men (34.5%; UI: 32.0–36.9) than women (31.7%; UI: 29.6–33.9) in 2019 (Fig. 2.8). Age-standardized coverage of treatment for hypertension among adults aged 30–79 years with hypertension largely increased between 1990 and 2019, with the pace of increase slowing down slightly during the past decade, among both men and women. In contrast to hypertension prevalence, which was 2.8 percentage points higher among men than women in 2019, treatment prevalence was 9.3 percentage points higher among women (47.2%; UI: 43.4–50.9) than men (37.9%; UI: 34.5–41.1) in 2019. Consequently, age-standardized prevalence of controlled hypertension among adults aged 30–79 years with hypertension also increased between 1990 and 2019, with faster improvements among women than men, leading to an increase in sex-related absolute inequality over time. In 2019, controlled hypertension prevalence was 5.1 percentage points higher among women (23.5%; UI: 20.4–26.9) than men (18.4%; UI: 15.9–21.2). 4 Defined as systolic blood pressure (SBP) ≥ 140 mmHg or diastolic blood pressure (DBP) ≥ 90 mmHg, regardless of diagnosis or medication status. 38\n",
            "\n",
            "score=0.4408| text=The global coverage of safely managed drinking water (SDG indicator 6.1.1) increased from 69% in 2015 to 73% in 2022, rising from 56% to 62% in rural areas and from 80% to 81% in urban areas. The coverage also varied greatly across WHO regions: in 2022, while nine out of 10 (92%) people in the European Region had access to safely managed drinking-water, only one third (33%) of people in the African Region did. To achieve the SDG target of universal access by 2030, the overall rate of progress will need to increase sixfold (40). Since 2015, the global coverage of safely managed sanitation (SDG indicator 6.2.1) has increased from 49% to 57% in 2022, rising from 36% to 46% in rural areas and from 60% to 65% in urban areas. The African Region remained the WHO region with the lowest overall coverage, from 23% in 2015 to 26% in 2022. The South East Asia and Western Pacific regions experienced the largest increases during the same period, reaching 49% and 68%, respectively, in 2022. To achieve universal access by 2030, the global rate of progress will need to increase fivefold (40). In 2022, the global coverage of basic hygiene services (SDG indicator 6.2.2) reached 75%, up from 67% in 2015. The coverage rose from 53% to 65% in rural areas, but remained stable at around 83% in urban areas. Overall coverage also remained largely unchanged in the African Region at 26%, as the gain in rural areas was offset by the decline in coverage in urban areas from 40% in 2015 to 36% in 2022. To achieve universal access by 2030, the global rate of progress will need to increase threefold (40). The proportion of total, domestic and industrial wastewater flows that are safely treated is monitored by SDG indicator 6.3.1. Wastewater statistics, however, are at an early stage of development in many countries and there is a lack of reporting, especially from industrial sources. Among the 73 countries (representing 42% of the global population) reporting volumes of total wastewater generated and treated, 76% of total wastewater flows received some level of treatment in 2022. Among the 42 countries (representing 12% of the population) reporting the type of treatment received, 60% of total wastewater flows had at least secondary treatment. In a separate calculation based on data from 140 countries and areas (representing 92% of all household wastewater flows), an estimated 58% of household wastewater was safely treated in 2022 (41). Many low- and middle-income countries lack domestic resources to improve the water sector. Between 2021 and 2022, official development assistance (ODA) disbursements to the water sector (SDG indicator 6.a.1) rose by 11% to US$ 9.1 billion, a rebound from the declining trend seen over the previous five years. ODA commitments also increased by 16% to US$ 11.4 billion. However, water sector ODA disbursements as a percentage of total ODA across all sectors decreased to 3.2% in 2022, a historical low, and continuing a downwards trend which has accelerated since the start of the COVID-19 pandemic in 2020 (42). These trends show that while progress towards universal access to safe WASH has been made in some areas, there are still some gaps in data and service coverage. Sustained actions to promote equitable access to WASH services are necessary to tackle these challenges. Air pollution The use of clean cooking fuels and technologies significantly reduces exposure to household air pollution, particularly among women and children who spend the most time near the domestic hearth. Globally, the proportion of population with primary reliance on clean fuels and technologies for cooking (SDG indicator 7.1.2) steadily improved from 49% in 2000 to 64% in 2015 and 74% in 2022. The access deficit therefore decreased from about half of the world’s population in 2000, to a little over a third in 2015 and about a quarter in 2022. However, this means that 2.1 billion people were still relying on polluting fuels and technologies for cooking in 2022, and the target of universal access by 2030 will not be met if current trends continue. Moreover, rural populations continued to have lower access than urban populations. Box 2.7 presents an analysis of the urban– rural inequalities globally and across WHO regions (43). Particulate matter (PM) is a common proxy indicator for air pollution. In 2019, almost all (99%) of the world’s population was exposed to unhealthy levels of fine PM. Globally, the annual average population-weighted concentration of fine PM in urban areas (SDG indicator 11.6.2) was 33 μg/m3 (UI: 32–34 μg/m3) in 2019, over six times the recommended level for protecting public health according to the WHO air quality guidelines (5 μg/m3). However, it stood at around interim target 1 of the guidelines (35 μg/m3), and the five-year average level of 2015–2019 (36 μg/m3) was 9% lower than that of 2010–2014 (39 μg/m3), signalling improvement in outdoor air quality globally. The Western Pacific Region saw the largest\n",
            "Answer: Yes, people are getting better access to clean water and sanitation. Between 2000 and 2022, approximately 2.1 billion people gained access to safely managed drinking water and 2.5 billion gained access to safely managed sanitation. Globally, the coverage of safely managed drinking water increased from 69% in 2015 to 73% in 2022, and safely managed sanitation increased from 49% to 57% during the same period.\n",
            "Waiting 5s for next question\n",
            "Conversation id: 4 Qid: 12 Qnum: 3 Question: What about health system readiness - how prepared are countries for health emergencies?\n",
            "score=0.3827| text=Figure 2.13 Health worker density and distribution, by World Bank income group, 2010–2022 (median values)a a Data were available for the three periods in 123 countries (46 high-income countries [HIC], 30 upper-middle-income countries [UMC], 33 lower-middle-income countries [LMC], 14 low-income countries [LICs]) for medical doctors, 119 countries (45 HIC, 33 UMC, 27 LMC, 14 LIC) for nursing and midwifery personnel, 98 countries (43 HIC, 26 UMC, 23 LMC, 6 LIC) for dentists and 100 countries (43 HIC, 20 UMC, 25 LMC, 12 LIC) for pharmacists. The income grouping refers to the World Bank analytical income of economies as of 1 July 2023, based on gross national income (GNI) per capita estimates for the year 2022 (59). Source: WHO (58). Implementing the International Health Regulations (IHR) and service delivery models that promote resilience The ability to prevent, detect and respond to health emergencies is a critical component of UHC. Service delivery models that are truly fit for purpose need to be equipped to implement the IHR and to develop a clear sense of the types of threats they may face and to prepare for them. The IHR States Parties Self-Assessment Annual Report (SPAR) tool consists of 35 indicators for the 15 IHR capacities needed to detect, assess, notify, report and respond to public health risks and acute events of domestic and international concern (SDG indicator 3.d.1). Based on the analysis of the latest annual reporting data, the top challenges at the global level are policy, legal and normative instruments to implement IHR (C.1), chemical events (C.14), radiation emergencies (C.15) and human resources (C.6); while the top strengths are laboratory (C.4), surveillance (C.5), health emergency management (C.7) and health services provision (C8). The European Region had the highest scores for the capacities related to zoonotic diseases (C.12), food safety (C.13), chemical events (C.14) and radiation emergencies (C.15), while the South-East Asia Region did particularly well for capacities related to policy, legal and normative instruments to implement IHR (C.1) and coordination and advocacy (C.2). The African Region had the lowest scores for all capacities with the exception of zoonotic diseases (C.12) (Fig. 2.14) (62). SPAR serves as a barometer for a nation’s preparedness and response, and helps understand not only national capacities in health security but also how they fit in a regional and international context. Box 2.8 describes the latest situation in Kiribati and how it relates to other Pacific island countries. 46\n",
            "\n",
            "score=0.3821| text=Figure 2.13 Health worker density and distribution, by World Bank income group, 2010–2022 (median values)a a Data were available for the three periods in 123 countries (46 high-income countries [HIC], 30 upper-middle-income countries [UMC], 33 lower-middle-income countries [LMC], 14 low-income countries [LICs]) for medical doctors, 119 countries (45 HIC, 33 UMC, 27 LMC, 14 LIC) for nursing and midwifery personnel, 98 countries (43 HIC, 26 UMC, 23 LMC, 6 LIC) for dentists and 100 countries (43 HIC, 20 UMC, 25 LMC, 12 LIC) for pharmacists. The income grouping refers to the World Bank analytical income of economies as of 1 July 2023, based on gross national income (GNI) per capita estimates for the year 2022 (59). Source: WHO (58). Implementing the International Health Regulations (IHR) and service delivery models that promote resilience The ability to prevent, detect and respond to health emergencies is a critical component of UHC. Service delivery models that are truly fit for purpose need to be equipped to implement the IHR and to develop a clear sense of the types of threats they may face and to prepare for them. The IHR States Parties Self-Assessment Annual Report (SPAR) tool consists of 35 indicators for the 15 IHR capacities needed to detect, assess, notify, report and respond to public health risks and acute events of domestic and international concern (SDG indicator 3.d.1). Based on the analysis of the latest annual reporting data, the top challenges at the global level are policy, legal and normative instruments to implement IHR (C.1), chemical events (C.14), radiation emergencies (C.15) and human resources (C.6); while the top strengths are laboratory (C.4), surveillance (C.5), health emergency management (C.7) and health services provision (C8). The European Region had the highest scores for the capacities related to zoonotic diseases (C.12), food safety (C.13), chemical events (C.14) and radiation emergencies (C.15), while the South-East Asia Region did particularly well for capacities related to policy, legal and normative instruments to implement IHR (C.1) and coordination and advocacy (C.2). The African Region had the lowest scores for all capacities with the exception of zoonotic diseases (C.12) (Fig. 2.14) (62). SPAR serves as a barometer for a nation’s preparedness and response, and helps understand not only national capacities in health security but also how they fit in a regional and international context. Box 2.8 describes the latest situation in Kiribati and how it relates to other Pacific island countries. 46\n",
            "\n",
            "score=0.3335| text=Figure 2.11 Percentage change in adolescent birth rate, by age group, and the proportion of births among adolescent girls out of total births, globally and by WHO region, 2015–2023 Health-related SDGs Source: UN DESA (44). 2.3 Health systems strengthening as a key means to achieve UHC In September 2023, at the United Nations General Assembly high-level meeting on UHC, political leaders reaffirmed their commitment to taking action for UHC (50). Building on the 2019 Political Declaration on UHC (51), the 2023 Political Declaration provides a roadmap to accelerate implementation towards achieving health for everyone, everywhere, and ensuring that no one is left behind. It acknowledges the importance of health systems strengthening based on a primary health care (PHC) approach, which is critical not just for centring people and communities, but also for effective health emergency prevention, preparedness, response and recovery, which has never been more salient than during the COVID-19 pandemic. UHC, grounded in the principle that all individuals and communities should have access to quality essential health services throughout the entire spectrum of care without enduring financial hardships, not only contributes to improving health outcomes (SDG 3) but also plays a pivotal role in other SDGs, including economic growth and job creation (SDG 8), gender equality (SDG 5), education (SDG 4), nutrition (SDG 2) and poverty reduction (SDG 1). Strengthening health systems and enhancing the sustainability and equity of health services and financing models are pivotal factors that contribute to the successful achievement of UHC. This section delves into SDG indicators related to service delivery and health financing, illustrating disparities across WHO regions and World Bank country income groups. 43\n",
            "Answer: Countries' preparedness for health emergencies is measured by the International Health Regulations (IHR) States Parties Self-Assessment Annual Report (SPAR) tool, which assesses 15 IHR capacities for detecting, assessing, notifying, reporting, and responding to public health risks. Globally, the top challenges identified are policy, legal, and normative instruments to implement IHR, chemical events, radiation emergencies, and human resources, while strengths include laboratory, surveillance, health emergency management, and health services provision. Regional performance varies, with the African Region generally having the lowest scores for most capacities, except for zoonotic diseases.\n",
            "Waiting 5s for next question\n",
            "Conversation id: 5 Qid: 13 Qnum: 1 Question: How much are countries spending on health?\n",
            "score=0.4383| text=Figure 2.16 Proportion of total government spending on health (%), by World Bank income group, 2000–2021 Note: The income grouping refers to the World Bank analytical income of economies as of 1 July 2022, based on GNI per capita estimates for the year 2021. Source: WHO (67) continues to constitute the largest share of health financing; the latest data shows that 2 billion people suffer financial hardship (impoverishing out-of-pocket health spending, catastrophic health spending or both) (52). The global proportion of the population with catastrophic OOP health spending at 10% thresholds (SDG indicator 3.8.2) continuously increased from 9.6% in 2000 to 12.7% in 2015 at the beginning of the SDG era and reached 13.5% in 2019, representing over 1 billion people (Fig. 2.17). The largest shares were reported in the Western Pacific Region (19.8%) and South-East Asia Region (16.1%); the lowest shares were reported in the Region of the Americas (7.8%) and the European Region (7.9%) (52). Even prior to the COVID-19 pandemic, and despite long standing high-level commitments to health for all and UHC, progress was largely off-track. Many governments have neglected foundational investments in health systems. Consequently, health services have been disrupted and inequities between and within countries have worsened during the COVID-19 pandemic. Achieving UHC requires targeted resource allocation and a renewed commitment to building resilient health systems that prioritize access to essential services for the poor and most vulnerable. 50\n",
            "\n",
            "score=0.4360| text=Figure 2.16 Proportion of total government spending on health (%), by World Bank income group, 2000–2021 Note: The income grouping refers to the World Bank analytical income of economies as of 1 July 2022, based on GNI per capita estimates for the year 2021. Source: WHO (67) continues to constitute the largest share of health financing; the latest data shows that 2 billion people suffer financial hardship (impoverishing out-of-pocket health spending, catastrophic health spending or both) (52). The global proportion of the population with catastrophic OOP health spending at 10% thresholds (SDG indicator 3.8.2) continuously increased from 9.6% in 2000 to 12.7% in 2015 at the beginning of the SDG era and reached 13.5% in 2019, representing over 1 billion people (Fig. 2.17). The largest shares were reported in the Western Pacific Region (19.8%) and South-East Asia Region (16.1%); the lowest shares were reported in the Region of the Americas (7.8%) and the European Region (7.9%) (52). Even prior to the COVID-19 pandemic, and despite long standing high-level commitments to health for all and UHC, progress was largely off-track. Many governments have neglected foundational investments in health systems. Consequently, health services have been disrupted and inequities between and within countries have worsened during the COVID-19 pandemic. Achieving UHC requires targeted resource allocation and a renewed commitment to building resilient health systems that prioritize access to essential services for the poor and most vulnerable. 50\n",
            "\n",
            "score=0.0932| text=Health-related SDGs SDG indicator 3.d.2 is defined as the percentage of bloodstream infections due to selected antimicrobial resistant organisms. Median resistance to third generation cephalosporins in Escherichia coli (E. coli) and methicillin resistance in Staphylococcus aureus (S. aureus) were 41% and 32% in 2021, respectively, compared with 26.9% and 13.4% in 2016. However, no conclusions can be made on whether changes in resistance have occurred over time. The reasons for this are twofold: first, the pool of reporting countries has changed significantly over the years. In 2016, only 16 countries contributed data on resistance to third-generation cephalosporins in E. coli, compared with 77 in 2021. Similarly, only 15 countries provided data in 2016 on methicillin resistance in S. aureus in 2016, compared with 78 in 2021. Second, the number of resource-limited settings providing data has increased in recent years. Testing coverage in these settings is often low, with data often limited to tertiary referral, private hospitals and/or research facilities, and biased towards complex infections and treatment failures. Higher median resistance in recent years is at least in part consistent with potential biases resulting from the convenience sampling of health facilities for reporting AMR data in many settings (26). Priorities to address AMR include surveillance of antimicrobial consumption. The Global Antimicrobial Resistance and Use Surveillance System (GLASS) provides a common and standardized set of methods for measuring and reporting. Of the 57 countries with data (2018–2021), 36 (63%) achieved the target of at least 60% of total antibiotic consumption being “Access” group antibiotics (26). The overall goal is to reduce the use of “Watch and reserve” group antibiotics and to increase the relative benefit and the availability of Access group antibiotics, where needed. 2.1.6 Polio Poliomyelitis (polio) is a highly infectious viral disease. It primarily affects children under 5 years of age, but an unvaccinated person at any age can contract the disease. Of the three strains of wild poliovirus (type 1, type 2 and type 3), wild poliovirus type 2 was eradicated in 1999 and wild poliovirus type 3 was eradicated in 2020. As at 2022, endemic wild poliovirus type 1 remains in two countries, Afghanistan and Pakistan. In 2023, a total of 12 cases of wild poliovirus were reported in Afghanistan and Pakistan and, unlike in previous years, no cases were reported from non-endemic countries (22). Although immunization coverage, including polio, began to recover from the impact of the COVID-19 pandemic during 2022, progress is uneven. There were 14.3 million children missing out on any vaccination – the so-called “zero-dose children” – worldwide in 2022. Afghanistan and Pakistan were among the top 15 countries with the highest number of zero-dose children in 2022, highlighting the need for continued, intensified efforts to reach all remaining un- or under-immunized children in those endemic areas (23). 2.1.7 Antimicrobial resistance AMR affects countries in all regions and at all income levels. It is a complex problem that requires both sector specific actions in the human health, food production, animal and environmental sectors, and a coordinated approach across these sectors. In 2015, the World Health Assembly adopted the Global Action Plan on AMR, committing, among other things, to the development and implementation of multisectoral national action plans (24). As of November 2023, some 178 countries had such plans developed. However, in 2023 only 27% of countries reported implementing their national action plans effectively and only 11% had allocated national budgets to do so (25). 33\n",
            "Answer: Government spending continues to constitute the largest share of health financing, with the proportion of total government spending on health by World Bank income group between 2000 and 2021 detailed in Figure 2.16.\n",
            "Waiting 5s for next question\n",
            "Conversation id: 5 Qid: 14 Qnum: 2 Question: Are people facing financial hardship from health costs?\n",
            "score=0.5068| text=Figure 2.15 SPAR scores by capacity in Kiribati, 2023 Health-related SDGs Source: WHO (62). 2.3.2 Health financing Health financing arrangements determine the ability of health systems to respond to health needs, pool financial risks, and operate efficiently and equitably. They span choices and decisions in three interlinked financing functions – mobilizing resources, pooling them and using them to strategically purchase health services. Mobilizing resources and prioritizing health The Addis Ababa Action Agenda (AAAA) recognized that the primary mechanism for meeting resource needs for achieving the SDGs should be domestic (65). In 2021, global government health spending (the health component of SDG indicator 1.a.2) surged, except in low-income countries (Fig. 2.16). High- and upper middle-income nations increased health priority due to COVID-19-related expenditures. In lower-middle-income countries, slower growth in health spending compared with general government spending resulted in reduced health priority in almost half of them, though outliers boosted the average. Among low-income countries, half saw declining health priority as reduced government health spending coincided with higher general spending. External aid likely played a significant role in financing health-care expenses related to the COVID-19 pandemic in low- and lower-middle-income nations, echoing a trend where higher external funding in low-income countries correlated with lower health priority in government budgets during the MDG period (66). Development assistance for health (DAH) to complement domestic financing As part of the AAAA, countries committed to reverse the decline in aid to the poorest and fragile countries, many of which will require sustained DAH to address capacity constraints and continue progress toward UHC. However, DAH must add to domestic resources rather than crowding them out, and support efforts to increase the effectiveness and efficiency of domestic resources utilization. In 2022, the African Region received the highest weighted average health ODA per capita (US$ 5.35) compared with countries in other regions (less than US$ 3 per capita) (SDG indicator 3.b.2) (42). While DAH has undeniably contributed to noteworthy health improvements, the current architecture and incentives associated with such assistance have inadvertently led many nations to neglect funding for basic health services in their own budgets and become overly aid-dependent (68). The COVID-19 pandemic has shown the perils of overdependence on external sources of finance and distant suppliers for critical health needs (69). Improve financial protection for all Expanding pooling arrangements is essential to provide protection from the economic consequences of ill health and enhance equity in service use – to reduce foregone care for financial reasons, financial hardship due to out of-pocket (OOP) health payments and indebtedness due to health cost. In many countries, direct household OOP 49\n",
            "\n",
            "score=0.5064| text=Figure 2.15 SPAR scores by capacity in Kiribati, 2023 Health-related SDGs Source: WHO (62). 2.3.2 Health financing Health financing arrangements determine the ability of health systems to respond to health needs, pool financial risks, and operate efficiently and equitably. They span choices and decisions in three interlinked financing functions – mobilizing resources, pooling them and using them to strategically purchase health services. Mobilizing resources and prioritizing health The Addis Ababa Action Agenda (AAAA) recognized that the primary mechanism for meeting resource needs for achieving the SDGs should be domestic (65). In 2021, global government health spending (the health component of SDG indicator 1.a.2) surged, except in low-income countries (Fig. 2.16). High- and upper middle-income nations increased health priority due to COVID-19-related expenditures. In lower-middle-income countries, slower growth in health spending compared with general government spending resulted in reduced health priority in almost half of them, though outliers boosted the average. Among low-income countries, half saw declining health priority as reduced government health spending coincided with higher general spending. External aid likely played a significant role in financing health-care expenses related to the COVID-19 pandemic in low- and lower-middle-income nations, echoing a trend where higher external funding in low-income countries correlated with lower health priority in government budgets during the MDG period (66). Development assistance for health (DAH) to complement domestic financing As part of the AAAA, countries committed to reverse the decline in aid to the poorest and fragile countries, many of which will require sustained DAH to address capacity constraints and continue progress toward UHC. However, DAH must add to domestic resources rather than crowding them out, and support efforts to increase the effectiveness and efficiency of domestic resources utilization. In 2022, the African Region received the highest weighted average health ODA per capita (US$ 5.35) compared with countries in other regions (less than US$ 3 per capita) (SDG indicator 3.b.2) (42). While DAH has undeniably contributed to noteworthy health improvements, the current architecture and incentives associated with such assistance have inadvertently led many nations to neglect funding for basic health services in their own budgets and become overly aid-dependent (68). The COVID-19 pandemic has shown the perils of overdependence on external sources of finance and distant suppliers for critical health needs (69). Improve financial protection for all Expanding pooling arrangements is essential to provide protection from the economic consequences of ill health and enhance equity in service use – to reduce foregone care for financial reasons, financial hardship due to out of-pocket (OOP) health payments and indebtedness due to health cost. In many countries, direct household OOP 49\n",
            "\n",
            "score=0.4882| text=Figure 2.16 Proportion of total government spending on health (%), by World Bank income group, 2000–2021 Note: The income grouping refers to the World Bank analytical income of economies as of 1 July 2022, based on GNI per capita estimates for the year 2021. Source: WHO (67) continues to constitute the largest share of health financing; the latest data shows that 2 billion people suffer financial hardship (impoverishing out-of-pocket health spending, catastrophic health spending or both) (52). The global proportion of the population with catastrophic OOP health spending at 10% thresholds (SDG indicator 3.8.2) continuously increased from 9.6% in 2000 to 12.7% in 2015 at the beginning of the SDG era and reached 13.5% in 2019, representing over 1 billion people (Fig. 2.17). The largest shares were reported in the Western Pacific Region (19.8%) and South-East Asia Region (16.1%); the lowest shares were reported in the Region of the Americas (7.8%) and the European Region (7.9%) (52). Even prior to the COVID-19 pandemic, and despite long standing high-level commitments to health for all and UHC, progress was largely off-track. Many governments have neglected foundational investments in health systems. Consequently, health services have been disrupted and inequities between and within countries have worsened during the COVID-19 pandemic. Achieving UHC requires targeted resource allocation and a renewed commitment to building resilient health systems that prioritize access to essential services for the poor and most vulnerable. 50\n",
            "Answer: Yes, people are facing financial hardship from health costs, with the latest data indicating that 2 billion people suffer financial hardship due to impoverishing or catastrophic out-of-pocket health spending. The global proportion of the population experiencing catastrophic out-of-pocket health spending reached 13.5% in 2019, affecting over 1 billion people.\n",
            "Waiting 5s for next question\n",
            "Wrote submission.csv (14 rows)\n"
          ]
        }
      ],
      "source": [
        "build_submission(\"Questions.csv\", \"Answers.csv\")"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "ksCfyj-g4CVR"
      },
      "outputs": [],
      "source": []
    }
  ],
  "metadata": {
    "accelerator": "GPU",
    "colab": {
      "gpuType": "T4",
      "provenance": []
    },
    "kernelspec": {
      "display_name": "spark",
      "language": "python",
      "name": "python3"
    },
    "language_info": {
      "codemirror_mode": {
        "name": "ipython",
        "version": 3
      },
      "file_extension": ".py",
      "mimetype": "text/x-python",
      "name": "python",
      "nbconvert_exporter": "python",
      "pygments_lexer": "ipython3",
      "version": "3.13.2"
    }
  },
  "nbformat": 4,
  "nbformat_minor": 0
}
